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Ministerial Foreword  
 
I welcome the publication of the first NHQRS annual report. I have set improving patient 
outcomes and patient safety as one of my priorities for 2015 and beyond. I am a strong 
believer in transparency and open data. As they say, if you don't measure it, you cannot 
improve it and without regular measurement and reporting you cannot know if your policies 
and reforms are actually making a positive difference.  
 
Some people in the health sector will be uneasy with the new approach. They will be 
concerned that statistics will not be contextualised and may even be sensationalised causing 
unnecessary concern and worry for patients and their families. I understand this concern but I 
do not agree. We need to trust people with the truth and the facts.  
 
It's important, however, that the information in this report is used responsibly. Variations in 
patient outcomes from country to country, county to county and hospital to hospital do not 
necessarily suggest different standards or quality of care. Sometimes the variance is not 
statistically significant (i.e. it is within the margin of error).  Sometimes it is down to the way 
data is collected. And of course, countries and counties vary in terms of population health, 
socioeconomic profile and transience of population. A hospital might have a higher mortality 
rate than another not because the care is inferior but rather because it is a specialist centre and 
therefore takes the sickest patients. Rather, I see variance as an amber flag, a cue telling us to 
look deeper and seek a further explanation for any variance in patient outcomes so that we 
can address it if we can.  
 
Unfortunately there are no standardised patient experience surveys across the health sector. I 
have asked the HSE and the Department of Health to address this gap, so that we can include 
patient experience as a measure in next year‟s report. 
 
All in all, this report demonstrates that patient outcomes are improving on a number of fronts. 
Vaccine uptake is increasing and MRSA and C. Difficile infection rates are going down. 
People who have been admitted to hospital with a heart attack are much more like to survive 
now than a few years ago and cancer survival rates are catching up with Western norms.  
 
But there is clearly also much room for improvement. Cancer survival rates are below the 
OECD countries average though it is too soon for these statistics to show the impact of recent 
developments in services such as the extension of screening and development of designated 
cancer centres. Rates of hospitalisation for COPD are higher than in other countries in the 
OECD and there is a lot of variation from county to county. The same applies to Caesarean 
Section rates with some variation from hospital to hospital.  
 
I look forward to next year's annual report which I hope will show some improvement and 
will include new data on patients' views on their own experience of the health service.  
 
Leo Varadkar T.D. 
Minister for Health
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Glossary 
 
OECD: Organisation for Economic Co-operation and Development. A group of 34 countries 
that compares how each one is performing in areas such as health, employment and 
education. 
 
ICD-10-AM: International Statistical Classification of Diseases and Related Health 
Problems, Tenth Revision, Australian Modification. A system that allows all medical 
conditions and procedures to be converted into codes for analysis. 
 
HIPE: Hospital In-Patient Enquiry database. A system that collects clinical and 
administrative information on patients each time they are admitted to a public hospital in 
Ireland.  
 
Principal Diagnosis: The diagnosis established after study to be chiefly responsible for 
occasioning the episode of admitted patient care. 
 
95% Confidence Interval: When a result has a high and low range attached, this range is 
called a confidence interval. There is a 95 per cent chance that the real result lies within this 
high and low range.  
 
Statistically significant: A result is said to be statistically significant when the chance of it 
being true is equal to or greater than 95 per cent. 
 
Age-sex standardised death rate (ASDR): This allows the death rate in one hospital or 
country to be compared against the death rate in another hospital or country. It takes into 
account the differences in age and sex between the different hospitals or countries. 
 
Comorbidities: When there are two or more diseases existing at the same time in the body. 
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Introduction 
This is the first annual report of the National Healthcare Quality Reporting System 
(NHQRS). The establishment of the NHQRS was announced in February 2014 by the 
Minister for Health as part of his commitment to the public reporting of quality indicators 
that reflect on the quality and safety of health care in Ireland. 
Public reporting about the quality of health care helps to drive improvements in the quality of 
the care provided to patients. The NHQRS will report on health care quality using 
performance measures or indicators and report them at national, regional, and hospital level 
to allow for national and international comparison. Each year the Health Service Executive 
(HSE) publishes its service plan which includes a number of measures related to quality of 
care. However this information is primarily for performance management and, while 
published on the HSE website, is not presented in a format that is readily accessible to the 
public. The NHQRS annual report aims to provide information on the quality and safety of 
health care services that can be easily understood and used by patients, members of the 
public, policy makers and service providers to assist them in making informed decisions 
about their own health care and about health care services in Ireland.  
In early 2015, the Minister for Health announced his priorities for the health system which 
included a focus on improving patient outcomes. The information selected for inclusion in the 
NHQRS is aligned with and supports decision making for these priority areas. 
The report is presented in two sections:  
 Section 1: sets out the background to quality reporting and the aims, objectives and 
governance structures of the NHQRS. It also sets out the framework, with the agreed 
quality domains, for national quality reporting. The indicators selected for the Annual 
Report 2014 are also described. 
 Section 2: presents the indicator analysis for this annual report with each indicator 
presented under the relevant domain.  
 
For each indicator the report sets out the rationale, and the findings. The presentation level 
can be at national level, regional/county level or hospital level depending on what is the most 
appropriate and informative level to present the data. Accompanying each indicator is text 
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which provides commentary on the findings, for example, if there are any variations at 
international, national, county or hospital level.   
Who can use this report 
This report has been designed so that the information presented is as accessible as possible to 
all audiences. There are a number of specifically intended audiences for this report however, 
the most important being patients, their families and the general public. Therefore, the 
information is presented so that patients and the public can access information about their 
own county, their local health services, and the hospitals they attend. The report sets out the 
information in user-friendly language. However it is recognised that the language reflects the 
health care services being reviewed and therefore, it is not always possible to use language 
that is free from technical terms. 
 
The people providing the services are another important audience.  Therefore, as well as at 
national level the information is presented at regional, local health area, hospital group and 
hospital level so they, the service providers, can see how their organisation or service is 
performing and allowing comparison to other similar services.  
 
By presenting performance measures at national level and comparing with international 
measures, policy makers and service providers can compare the performance of Irish health 
services with health services in other countries.  This information can be used to plan, 
monitor and drive service improvement at all levels, including national level. Importantly, 
this information can also be used to support evidence-based policy making. 
How to use this report 
The performance indicators selected for this first annual report reflect on the quality and 
performance of services across the health system but it is important that what they tell us is 
not over interpreted.  
The indicators in this report are high level indicators that highlight the general direction and 
trend in relation to how services are performing over time. This is done by both comparing 
the service to itself and also comparing to other services both in Ireland and internationally. 
The indicators draw attention to issues that need further exploration and analysis. These 
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indicators are not intended to be direct measures of the quality of the services. Their value is 
that they provide an alert that further exploration and analysis is needed to determine if, and 
why, differences in the indicators exist and the causes of these differences.  These indicators 
work rather like smoke alarms – the alarm attracts people‟s attention but to find out if there is 
an actual fire, what caused it and how to prevent it happening again, then further exploration 
is required.   
Differences can be due to many reasons. For example, issues like the quality of the data 
collected, differences due to patients attending one service being more unwell with more 
complex needs than those attending other services, or differences related to the quality of the 
service provided.  Indicators can also help to identify good practice from which other services 
can learn. If an analysis highlights variation in outcomes across health care services, for 
example, between counties or services then this needs to be further explored and addressed. 
This is so patients receive the same type and quality of care regardless of where they are in 
the country or which service they attend. 
 
It is also important to remember that one indicator alone should not be used to measure 
whether an organisation or service is safe and providing quality care. A single measure or 
indicator cannot capture all aspects of the health care provided and the quality of that care. 
Therefore, indicators should not be used in isolation but rather used with other indicators to 
assess the quality of care being provided by a service or organisation. For this report a 
relatively small number of indicators were available and therefore, selected. However, it is 
important to note that in future annual reports, more quality indicators of different types will 
be included to provide a more comprehensive view of the quality of services being delivered.  
 
This report provides the basis for a very important public discussion about the quality of 
health services in Ireland.  The appropriate response to any reported differences in indicators 
is for the service providers to further explore and to explain the positive and negative 
findings. This may require more in depth analysis and evaluation to examine the differences 
and the underlying reasons for them.  
One of the challenges in developing quality measures for the Irish health system has been that 
it is difficult to track a patient‟s journey through the health system as there is no unique 
patient identifier. However, this is being addressed through the Health Identifiers Act 2014, 
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which provides the legal basis for the development and introduction of unique patient 
identifiers in Ireland. Therefore, in the future it will be possible to track a patient‟s journey 
between services, for example, between hospital services and community services. This will 
make it possible to track a patient‟s health status as they move from one service to another.  
To allow for international comparisons the findings for all of the indicators are presented at 
national level and compared, where relevant and available, with international findings. For 
many of the indicators this means comparison with other countries in the Organisation for 
Economic Cooperation and Development (OECD). However, it is important to note that there 
may be variation between countries in their coding practices, in the definitions used, and in 
the disease classification systems used. For example, Ireland uses the disease classification 
system ICD-10-AM whereas many other countries use ICD-9 based classifications. 
Therefore, these differences in coding practices among countries and differences in disease 
classification systems may affect data comparability between these countries. It is also 
important to note that, in using definitions that allow for international comparison, it is often 
necessary to use less detailed information than is available in Ireland. This results in some 
measures in this report being different to those used by the HSE.   
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Section 1:  
National Healthcare Quality Reporting System 
 
Chapter 1: Why a National Healthcare Quality Reporting System 
 
1.1 Background 
It is internationally accepted that for health services to provide high quality safe care they 
need to measure and monitor the quality of that care. They need to learn from good quality 
care and improve the quality if it falls below the expectations of patients, the public, policy 
makers, and the service providers themselves.  
 
To drive improvements in the quality and safety of health care many countries have put in 
place systems for measuring, monitoring and publicly reporting on the performance of their 
health services. It is recognised that in health care, as in other arenas, it is difficult to improve 
what cannot, or is not, measured (1). The importance of measuring and comparing 
performance in delivering quality health care outcomes between countries has also been 
recognised and facilitated by the establishment of international quality reporting systems, for 
example the OECD Health Care Quality Indicators.  
 
Such systems in other countries allow for the measuring, monitoring and public reporting on 
the quality of health care at regional, national and international level. They empower patients 
and service users to make informed decisions about their health care, help health care 
providers to improve their performance through benchmarking with other services, and they 
facilitate system-wide quality improvement in health care by informing national policies. 
 
In Ireland large amounts of health data are collected through several information systems 
such as the Hospital Inpatient Enquiry System (HIPE), the National Cancer Registry of 
Ireland, and the Computerised Infectious Disease Reporting (CIDR). These information 
sources are used in various ways to measure, monitor and report on a number of health care 
related activities and outcomes. Indicators derived from these different information systems 
are used by the HSE through the service plan to monitor their performance on the quality of 
clinical care. However, these indicators have not previously been collated in a single report to 
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provide an overall picture of the quality of health care in Ireland with the key aim of 
informing patients and their families. 
 
The Department of Health carried out an assessment of the feasibility of one of the largest 
health care information resources in Ireland, Hospital Inpatient Enquiry (HIPE), as a source 
for deriving quality indicators. This led to the publication of “Health Care Quality Indicators 
in the Irish Health System: Examining the Potential of Hospital Discharge Data using the 
Hospital Inpatient Enquiry System” in February 2014 (2). The report found that HIPE was a 
feasible source to derive quality indicators and it could be used in the future to monitor the 
quality of health care in Ireland.  
 
At the time of publication of the above named report, the Minister for Health announced the 
establishment of the National Healthcare Quality Reporting System (NHQRS) for Ireland.  
 
The Minister for Health, with the establishment of the NHQRS, committed to public 
reporting of information on the quality and safety of health care in Ireland. This is based on a 
commitment to openness, transparency, improving accountability within the health system 
and on an understanding that such public reporting of information on performance will help 
drive improvements in the quality of the care being delivered in the Irish health services.  
 
This reporting system will publicly report indicators that reflect on the quality and safety of 
health care across the Irish health system and, wherever possible, will be aligned with 
evidence-based international practice and linked to international norms, e.g. OECD Health 
Care Quality Indicators.  
 
1.2 Monitoring and reporting the quality of health care 
Monitoring the quality of health care includes measuring the performance of a service against 
a standard or expected level of performance. 
 
It is accepted that performance measurement contributes to improving the quality of health 
care. This happens in a number of ways: 
 Firstly, it drives improvement by providing patients and service users with 
information about the quality of health care and the performance of services in 
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providing this care. Patients, service users, their families and members of the public 
can then make informed choices about their health care both at an individual level but 
also at population level.  Engaging patients in this way drives improvement in 
outcomes for patients.   
 Secondly, performance measurement supports improvement through comparing the 
performance of individuals, teams or organisations. This comparison can result in a 
desire to improve or maintain performance relative to others, thus improving quality 
and safety of services provided.  
 Finally, it is recognised from research that professionals have an intrinsic desire to 
improve their performance when they are made aware, through performance 
measurement, that there is potential for improvement. 
Therefore, the use of performance measures supports the improvement in the quality of health 
care including improving patient outcomes. One of the ways to measure performance is 
through the use of key performance indicators (KPIs). KPIs are specific and measurable 
elements of health care that can be used to assess quality of care (3). They are measures of 
performance, based on standards determined through evidence-based academic literature or 
through the consensus of experts when evidence is unavailable (3). They usually have 
specific targets and in this report agreed international or national targets associated with the 
selected indicators will be stated.  
For the NHQRS it is important that the selected indicators measure performance in all the 
different sectors of health care such as services for preventative care, primary care, 
community care, and acute care.  
 
It is accepted that performance indicators are alerts or flags to identify variations in 
performance that may require further exploration to determine the reason behind the 
variation. Indicators can also help to identify good practice from which learning can be used 
throughout the system. However, it must be noted that the international literature on 
performance indicators warns against using only one measure as an overall indicator of an 
organisation‟s performance and safety. For example, there are significant limitations in 
interpreting in-hospital mortality rates and hospital performance (4). Indicators should be 
assessed within the context in which care is delivered and should not be reviewed in isolation. 
Therefore, it is important that a range of indicators are used that reflect different aspects of a 
service‟s performance.  
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A reporting framework for the NHQRS has been developed that sets out in domains the high level 
patient focused outcomes that a high quality health care service should achieve.  The selected 
indicators in these domains measure an aspect of care that contributes to the achievement of 
the domain.  
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Chapter 2: Governance of the National Healthcare Quality 
Reporting System 
 
The development of the NHQRS and its governance structure was led by the Chief Medical 
Officer‟s (CMO) Office in the Department for Health.  
2.1 Aim and Objectives of the National Healthcare Quality Reporting System 
The overall aim of the National Healthcare Quality Reporting System (NHQRS) is to 
facilitate improvements in outcomes for patients by ensuring the provision of 
information on the quality of health care to support health care decision making by 
patients, policy makers and service providers.  
This will be done through: 
 providing and reporting information that is orientated towards outcomes that matter to 
patients,  
 measuring and reporting on public health services performance,  
 enabling informed accountability, 
 supporting the dissemination of learning throughout the health system.   
 
Objectives 
The main objective of the reporting system is to provide publicly available information. This 
information can be used to compare performance at a national, regional and hospital level, as 
well as at international level, and can be used to hold the health system to account. 
 
The reporting system will focus on outcomes for patients and service users and reflect the 
care they receive in the different sectors of the health system, including preventative care, 
primary and community care, and secondary and tertiary care provided in hospitals. It is 
intended that the outcomes will also be aligned with the life-course so that the measures 
reflect the quality of care provided from pre-natal through to end of life. 
 
The objectives include the publication of an annual report.  It is envisaged that the NHQRS 
and the selected indicators reported each year will evolve over time. The indicators selected 
for the first report were indicators that: were feasible, in that they were available and 
collected within the health system; there were agreed definitions for; reflect on different 
areas/domains of the health system and that were considered important to the people using 
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the system, the public, and the service providers. However, there are currently gaps in the 
availability of indicators. For example, there are no patient experience measures in this first 
report. 
2.2 Governance Structures 
A National Healthcare Quality Reporting System Governance Committee was established to 
provide oversight and advice on the strategic direction of the NHQRS, agree the selected 
indicators, including definitions and metadata for inclusion in the NHQRS, and prepare and 
present an annual report to the Minister for Health. The committee members also provide 
leadership in relation to the NHQRS within their own organisations.  
 
The membership of this governance committee includes representation of patients, clinicians, 
the Acute Hospitals Division, Health and Wellbeing Division, the Quality Improvement 
Division and the Clinical Care and Strategy Programme of the HSE; the Acute Hospitals Unit  
and the Information Unit, Department of Health; the State Claims Agency; the Health 
Information and Quality Authority (HIQA); the Mental Health Commission and the acute 
Voluntary Hospitals (see Appendix 1).   
 
The committee agreed the Framework for the National Healthcare Quality Reporting System 
(NHQRS) and the selected indicators presented in this first annual report.  
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Chapter 3: Framework for National Healthcare Quality Reporting 
 
In developing the NHQRS it was important to describe the high level patient focused 
outcomes that a high quality health care service should deliver. These outcomes are described 
as quality domains. These domains and dimensions of quality are informed by international 
evidence of what quality health care looks like as well as the description given in the National 
Standards for Safer Better Healthcare (5). The domains and quality dimensions are also 
informed by outcomes used in reporting systems in other jurisdictions including the NHS 
Outcomes Framework (6), the Agency for Healthcare Research and Quality (AHRQ) (7), the 
Swedish Regional Comparisons (8), and the OECD framework for health system 
performance assessment (9). Internationally quality dimensions are used to describe high 
quality care. Examples of the commonly used quality dimensions are effective care, person-
centred care and/or safe care. Indicators under the Framework‟s domains will also reflect 
these quality dimensions. For example indicators under domain 5 will also reflect the quality 
dimension of safe care and indicators in the first three domains of the Framework will mainly 
reflect the quality dimension of effective care.  
 
 
 
Framework for National Healthcare Quality Reporting System 
Domain 1: Helping people to stay healthy and well 
 
Domain 2: Supporting people with long term conditions 
 
Domain 3: Helping people when they are being treated and cared for in our 
health services 
Domain 4: Supporting people to have positive experiences of health care 
 
Domain 5: Treating and caring for people in a safe environment 
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Chapter 4:  Indicators selected for the Annual Report 2014 
 
4.1 Selection process for indicators 
A process was undertaken to select the indicators for the first annual report. The selection 
process took into account that this is the first annual report and that the NHQRS will evolve 
over time as more high quality information is collected, and as it becomes more embedded in 
the health system. It was agreed by the governance committee that the criteria for the 
selection of the cohort of indicators for the first annual report were:  
 availability of data  in the Irish health system,  
 alignment to international indicators to allow for international comparison,  
 face validity of each indicator, i.e. sound clinical or scientific rationale for its use and 
measurement of an important aspect of quality that may be within the control of the 
provider or health care system 
 a focus on patient outcomes, patient safety and patient care  
 importance to patients 
 contribution to service improvement and cost efficiencies  
 alignment with the domains of the NHQRS framework  
 
The indicators selected took cognisance of the important factors for key performance 
indicators as outlined in the Health Information and Quality Authority‟s (HIQA), Guidelines 
on Developing of Key Performance Indicators and Minimum Data Sets to Monitor 
Healthcare Quality (3).  
 
These selected and reported indicators can inform and support the health care decisions of 
individual patients and also the decisions of service providers in designing, planning and 
delivering health care.  
 
Patient experience is internationally recognised as an important measure of the quality of 
health services. Research has associated positive patient experience with improved outcomes   
for patients (10). Internationally, there are many methods of measuring patient experience 
and in Ireland, there have been a number of patient experience surveys carried out with the 
most recent national survey carried out in 2010 (www.isqsh.ie accessed 20 January 2015).  A 
number of ad hoc surveys have been carried out in some hospitals at a local level. However, a 
16 | P a g e                  NHQRS Annual Report                                
 
standardised approach is not being used at present in all services provided by the HSE and so 
comparison and validation of these surveys is challenging.  Therefore, an indicator under the 
domain “Supporting people to have positive experiences of health care” is not included in the 
annual report 2014.  
 
In measuring the quality of care across health services, it is important that any measures 
cover not just acute care, but the other aspects of care, including staying healthy, getting 
better, and living with illness or disability and that the care and services provided to patients 
is person centred and delivered in a safe environment. However, for the first annual report it 
was agreed that the main focus would be on monitoring and reporting performance measures 
in the Acute Hospital sector. 
 
In this first report adverse events have not been included in the selected indicators under 
domain 5 “Treating and caring for people in a safe environment”. This is because the data 
and information relating to these events has not been yet fully developed and agreed at a 
national level.   
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4.2 Domains and selected indicators  
Table 1: Indicators in the Annual Report 2014 
Domain Indicator 
1. Helping people 
to stay healthy 
and well 
Immunisation rates 
Immunisation rate for MMR at 24 months of age 
Immunisation rate for Men C at 24 months of age  
Immunisation against influenza for persons aged 65 years and older with 
medical cards 
Cancer screening rates 
Percentage uptake of breast screening 
Percentage uptake of cervical screening 
2. Supporting 
people with long 
term conditions 
Ambulatory care sensitive conditions 
Chronic obstructive pulmonary disease (COPD) hospitalisation rates 
Asthma hospitalisation rates 
Diabetes hospitalisation rates 
3. Helping people 
when they are 
being treated and 
cared for in our 
health services 
Cancer survival rates 
Five year relative survival rate for breast cancer 
Five year relative survival rate for cervical cancer 
Five year relative survival rate for colorectal cancer 
Acute hospital care 
In-hospital mortality within 30 days of admission for acute myocardial 
infarction (AMI / heart attack) 
In-hospital mortality within 30 days of admission for haemorrhagic stroke 
In-hospital mortality within 30 days of admission for ischaemic stroke 
In-hospital waiting time for hip fracture surgery 
Caesarean section rates 
4. Supporting 
people to have 
positive 
experiences of 
health care 
Indicators to be developed for reporting in Annual Report 2015 
5. Treating and 
caring for people 
in a safe 
environment  
Health care associated infection rates 
Methicillin Resistant Staphylococcal Aureus (MRSA) rates 
Clostridium Difficile (C. difficile) rates 
 
Each domain is populated with a number of indicators. The exception is Domain 4: 
„Supporting people to have positive experiences of health care‟. For this domain there is 
currently no standardised methodology being used to collect data in the health system and 
therefore, this indicator is not included in the report.  However, this is a recognised gap and is 
an issue that will be further explored by the NHQRS Governance Group with the intention of 
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reporting an appropriate indicator in the next annual report. The rationale for the selected 
indicators and indicator groups in each domain is set out below.  
 
 4.3 Rationale for selected indicators  
The indicators included in this report are ones that meet the selection criteria set out in 
section 4.1.  
 
This section sets out why the selected indicators are important and which domains they sit 
under. 
 
Domain 1: Helping people to stay healthy and well 
 Immunisation rates 
 Cancer screening rates 
Immunisation Rates 
Immunisation (getting a vaccine and becoming immune) is a simple and safe way of 
protecting people against harmful diseases such as diphtheria, whooping cough, polio, 
measles, mumps and rubella.  These diseases can cause serious illness and complications 
such as long term disability and death. Getting immunised also protects other individuals in 
the community from these diseases who are either too young or too sick to receive the 
vaccines. Therefore, many countries including Ireland have introduced immunisation 
programmes for their populations.  
 
This report focuses on two of the childhood vaccines, MMR (measles, mumps and rubella) 
and Men C (meningococcal C). Both of these vaccines have had issues in relation to their 
uptake. The MMR vaccine uptake has varied over the years and this may have contributed to 
a number of outbreaks of measles, mumps and rubella over time and there was a sharp drop 
in uptake for Men C.  
 
Influenza vaccine is recommended for anyone aged 6 months or older in specific at-risk 
groups including adults over the age of 65 years.  This is because people with chronic 
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medical conditions or aged over 65 years are more likely to become seriously ill with 
influenza which can also lead to increased hospital admissions. 
 
MMR, Men C and Influenza vaccine uptake rates provide information on the performance of 
immunisation programmes in Ireland.  
 
Cancer Screening Rates 
Screening for cancer helps prevent significant illness and death by detecting cancer at an 
earlier and therefore, more treatable stage. In Ireland there are screening programmes for 
breast, cervical and colorectal cancers. Many countries monitor cancer screening uptake rates 
as they are an important measure of the performance and quality of preventative services and 
early detection. Public reporting of the rates also increases awareness and knowledge of these 
cancers in the population. 
  
In this report the cancer screening rates for breast and cervical cancers are included. The 
colorectal cancer screening programme commenced in 2012 but, as it was a phased 
programme, its screening rates are not included. 
 
Breast cancer is the most common form of cancer in women, with the exception of non-
melanoma skin cancer (www.ncri.ie. accessed 23
rd
 January 2015). One in nine women will 
develop breast cancer at some point in their life. BreastCheck is the national breast cancer 
screening programme which offers women aged 50 to 64 years a free mammogram every two 
years. The uptake target is 70% of the eligible population. Again, excluding non-melanoma 
skin cancer, cervical cancer is the 8
th
 most common cancer (www.ncri.ie. accessed 23
rd
 
January 2015), diagnosed among women in Ireland and its incidence has increased between 
2001 and 2011. The main cause of cervical cancer is sexual exposure to the human papilloma 
virus (HPV). CervicalCheck is the national cervical screening programme in Ireland and 
provides free smear tests to women aged 25-60 years. The target for coverage is 80% of the 
eligible population. 
 
The screening rates for both the breast and cervical cancer programmes are presented in this 
report and are a reflection of the quality of preventative services available in Ireland.   
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Domain 2: Supporting People with Long Term Conditions 
 Ambulatory care sensitive conditions 
Ambulatory care sensitive conditions 
Ambulatory care sensitive conditions are those where good quality primary care can help 
prevent the need for hospital admission or for which early intervention can prevent 
complications or more severe disease.  Data which shows the number of hospitalisations for 
different chronic conditions can give an insight into the performance and quality of services 
for these conditions in primary care. Avoiding hospital admissions is of benefit to the patient 
and the health service.   
 
Asthma, chronic obstructive pulmonary disease (COPD), and diabetes are three relatively 
common conditions in Ireland and hospital admissions due to these conditions are presented 
in this report. The treatment guidelines for these conditions are well established and suggest 
that most of it can be delivered at primary care level in the community.  
 
It is important to remember that the number of hospital admissions for ambulatory care 
sensitive conditions is also dependent on prevalence of the medical condition in the area, 
environmental conditions, and primary care access to diagnostic tests such as X-rays.  
 
While the need to go to hospital for these conditions will never be eliminated, differences 
between Ireland and other countries, and between counties in Ireland, indicate that there may 
be potential to improve the consistency of the care provided to these patients specifically in 
primary care. Indicators measuring hospital admissions for specific conditions are alerts 
rather than definitive measures of the quality of primary care services and only highlight the 
need for further analysis. 
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Domain 3: Helping people when they are being treated and cared for in our health services 
 Cancer Survival Rates 
 In-hospital Mortality Rates 
 In-hospital Waiting Time for Hip Fracture Surgery 
 Caesarean Section Rates 
Cancer Survival Rates 
Cancer survival is one of the key measures of the effectiveness of cancer care, taking into 
account both early detection of the disease and the effectiveness of treatment. A recent 
OECD report on cancer care showed that organised screening programmes for specific 
cancers, shorter waiting times, and the provision of evidence-based treatment were associated 
with improved survival (11). 
 
Cancer survival rates are reported by the OECD. In this first annual report, survival rates for 
breast, cervical, and colorectal cancers are compared between Ireland and other OECD 
countries and also between regions of Ireland.   
In-hospital Mortality Rates 
International experts consider in-hospital mortality rates to be useful high level indicators of 
the quality of hospital care when used in association with other measures of quality of care 
(12). Therefore, in this report in-hospital mortality indicators for acute myocardial infarction 
(AMI), haemorrhagic stroke, and ischaemic stroke are included. They are calculated using the 
OECD specifications to allow for comparison between countries. However, it must be noted 
that there are limitations associated with these three mortality indicators and this is discussed 
in the relevant section.  
In-hospital Waiting Time for Hip Fracture Surgery 
The Irish population is growing older. This results in more people having weaker bones 
(osteoporosis) and an increasing number of hip fractures. Generally, a short time between 
admission to hospital and performance of hip fracture surgery results in better outcomes for 
patients such as reduced length of stay in hospital. There can be many reasons for delays in 
performing hip fracture surgery, for example, the patient being too sick for surgery, but it can 
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also be due to avoidable administrative reasons. Therefore, an indicator on time to hip 
fracture surgery is used internationally as a measure of quality and is included in this report.  
Caesarean Section Rates 
The proportion of live births delivered by caesarean section has increased across the OECD 
with the average rate going up from 20% in 2000 to 27% in 2011. Some of the reasons 
proposed for this include, but are not limited to, increasing litigation, increases in first births 
among older women, and the rise in multiple births resulting from assisted reproduction. 
Most experts agree that high caesarean section rates are associated with increased maternal 
deaths, maternal and infant morbidity, and increased complications for subsequent 
pregnancies (13, 14). High caesarean section rates also have a greater financial cost for health 
services and there is some discussion about whether they are medically required.  Most 
professional associations of obstetricians and gynaecologists encourage the promotion of 
normal childbirth without interventions such as caesarean sections (15). Internationally, the 
rate of caesarean sections is considered an important measure of the quality of maternity 
services and is therefore, publicly reported. Caesarean section rates for relevant hospitals in 
Ireland are included in this report. 
Domain 4: Supporting people to have a positive experience of health care 
There are no indicators in this domain for the first annual report, but it is intended that 
appropriate indicators will be developed for inclusion in future annual reports. 
Domain 5: Treating and caring for people in a safe environment  
 Health Care Associated Infections 
Health Care Associated Infections 
Health care associated infections (HCAIs) are infections people catch while they are 
receiving treatment for another condition in a health care setting. This is most frequently 
while in hospital, but can also happen in the community. Most common health care 
associated infections only cause a minor illness. However, some health care associated 
infections can cause serious illnesses, such as blood infections. About one third of health care 
associated infections can be prevented by good hand-hygiene and appropriate care when 
dealing with patients. The reduction in the number of patients who acquire HCAIs is 
recognised as a measure of the quality and safety of care provided and therefore rates of 
HCAIs are included in this report. 
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Chapter 5: Future Developments of the National Healthcare Quality 
Reporting System 
 
This is the first NHQRS annual report. Since the announcement of the NHQRS in February 
2014, a governance structure and the framework with domains and selection criteria for 
selecting indicators for the first NHQRS annual report has been developed and agreed.  
 
This annual report sets out the first cohort of indicators selected for public reporting under the 
NHQRS framework. In selecting these domains and indicators gaps have been identified – 
specifically in relation to national indicators with a standardised approach for measuring 
patient experience. As patient experience indicators are important measures of the quality of 
the health care delivered by a health system, the intention is that over the next year these 
indicators, reflecting different services, for example, palliative care and end of life services, 
will be developed so that they can be included in the NHQRS Annual Report 2015. 
 
The presentation of some of the other indicators will be further explored and developed in the 
coming years. In the future, data may be presented in different ways to inform planning and 
policy development. For example, reporting cancer screening rates at a regional level, and 
reporting caesarean section rates for different groups of patients, such as first time mothers. 
Indicators in other domains will be continuously reviewed and developed so that future 
reports will more comprehensively reflect the performance of health services in delivering 
high quality safe health care.  
 
The gaps identified in this report in the data and information required for a complete picture 
of the quality of Irish health services, highlight the need for a focus on developing and 
improving good quality health information resources in Ireland.  
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Section 2:  
Indicator Analysis 
Overview of Analysis 
 
Each of the indicators presented in this report are set out to provide certain information. Each 
indicator is presented as a national trend, usually as a ten year trend where possible so that the 
national picture is clear. Each indicator is also compared, where information is available, with 
other countries so that Ireland‟s performance can be compared internationally. 
 
The indicators are then, again where data is available, presented at regional and local and, in 
some cases, hospital level, to give a clear picture of regional and local variations. 
 
It must be noted that for some of the indicators, age and sex were taken into account in the 
analysis so that they can be compared with the national average. As part of the age-sex 
standardisation adjustment, 95% confidence limits were calculated. If these resulting 
confidence intervals are outside the expected range they are statistically significant. This 
requires further exploration to determine the reason behind this variation. The fact that a rate 
is statistically significant does not mean that there is a difference in quality of care, either 
good or bad, but just suggests that this is different than the expected, and that the reasons 
must be looked into.  
 
The source of data and information for each of the indicators has been referred to under each 
indicator. The analysis presented in this report was carried out by the Information Unit of the 
Department of Health, but also by various agencies, including the National Cancer Registry 
of Ireland, the Health Protection Surveillance Centre and the National Cancer Screening 
Service, depending on the indicator selected. 
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Domain 1: Helping people to stay healthy and well 
 Immunisation rates 
 Cancer screening rates 
 
Immunisation rates 
Immunisation rates for MMR vaccine at 24 months 
 
Description 
Percentage of children who have received the MMR (measles, mumps and rubella) vaccine at 
24 months of age. 
Rationale for selection of indicator  
Measles, mumps and rubella were once high infectious common viral childhood diseases, 
which can cause serious complications and even death. In Ireland, two doses of MMR 
vaccine are given, the first dose at 12 months and the second dose at 4-5 years of age (16). 
However, there have been a number of outbreaks of measles and mumps in the last few years 
in Ireland and it is suggested that this may be due to decreases in vaccination rates following 
media scares about the safety of the MMR vaccine. These safety concerns have since been 
refuted, but there may still be population groups that are not reaching the vaccination rate 
required for community protection. Therefore, the national vaccination rate for MMR over 
the last ten years and the regional vaccination rates are presented in this report. In Ireland, the 
national target for uptake is 95% which is in line with international targets.  
 
Commentary 
 Figure 1 shows the national immunisation uptake rates of MMR for children at 24 
months of age from 2004 to 2013. Although the national target of 95% has not been 
achieved, the national immunisation rate has been increasing over the 10 year period 
with a rate of 93% in 2013.   
 Figure 2 shows the immunisation rate for MMR at 24 months by local health office in 
2013. The map shows that all counties had uptake rates greater than 88%.  
Roscommon local health office had the highest uptake in 2013, with 97.6% of 
children receiving the vaccine. The map shows different levels of MMR vaccine 
uptake across the country. The reasons why some areas have lower uptake than others 
needs further exploration.  
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Figure 1: MMR immunisation rates at 24 months, percentage uptake 2004 to 2013 
 
Source: Health Protection Surveillance Centre (HPSC)  
 
Figure 2: Immunisation rate for MMR for children at 24 months by Local Health Office, 2013 
 
 
Source: Health Protection Surveillance Centre (HPSC) 
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Immunisation rate for Meningococcal C vaccine for children at 24 months 
Description 
Percentage of children who have received 3
rd
 dose of Men C (Meningococcal C) vaccine by 
24 months of age. 
 
Rationale for selection of indicator  
Meningococcal C is an infectious bacteria that can causes meningitis or septicaemia (blood 
infection), or both.  The disease can cause death or serious disability such as deafness, brain 
damage, or loss of limbs. The meningococcal group C vaccine (Men C) was introduced in 
Ireland in October 2000. The current vaccine schedule in Ireland is three doses of Men C 
vaccine at 4 months, 6 months and 13 months of age. (17). In Ireland the national target for 
uptake is 95%, which is in line with international targets.  
 
Commentary 
 Figure 3 shows the third dose of Men C vaccine uptake rates of children of 24 months 
of age at national level for 2004 to 2013. This shows the uptake rates steadily 
increasing to a peak of 93% in 2009 after which there was a break in the trend. 
However, the uptake level has increased again in the last few years with 87% of 
children receiving the vaccine in 2013.  
 In September 2008, the childhood immunisation schedule was changed resulting in a 
change of timing for giving the Men C vaccination. This meant an additional visit to 
the GP at 13 months of age. In 2010, there was a large decline in reported uptake of 
the third dose of Men C. This affected children on the new schedule.  Research 
showed that most parents did not know their children were incompletely vaccinated 
and were unaware of the need for a 13
th
 month visit to the GP.  In response to the 
decrease in uptake, this information was communicated to GPs and updated 
information materials were developed for parents (18) and subsequently immunisation 
rates increased again. 
 Figure 4 shows the uptake rate for Men C vaccine at 24 months by local health office 
in 2013. Roscommon had the highest uptake and West Cork had the lowest uptake 
rate in 2013. The reasons for variation across the country in third dose Men C vaccine 
uptake needs to be further explored. 
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Figure 3: Third dose of Meningococcal C immunisation rates at 24 months, percentage uptake 2004 to 2013 
 
Source: Health Protection Surveillance Centre (HPSC) 
 
Figure 4: Immunisation rate for Men C for children at 24 months by Local Health Office, 2013 
 
Source: Health Protection Surveillance Centre (HPSC) 
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Immunisation against influenza for persons aged 65 and older with medical or GP only 
cards 
 
Description 
Percentage of people over the age of 65 years with a medical card or GP visit card, who have 
been vaccinated against influenza.  
Rationale for selection of indicator  
Influenza is a common infectious disease that affects between 5% and 15% of the population 
each year (19). Most people with the illness recover quickly, but elderly people and those 
with chronic medical conditions are at higher risk of complications and even death. Influenza 
can also have a major impact on health services particularly during the winter season. 
Vaccines provide a safe way of preventing influenza and have been shown to reduce the risk 
of death by up to 55% among healthy older adults as well as reduce the risk of hospitalisation 
by between 32% and 49% among older adults (20, 21). In 2003, countries participating in the 
World Health Assembly, including Ireland, committed to the goal of attaining vaccination 
coverage of the elderly population of at least 50% by 2006 and 75% by 2010 (22). In Ireland 
the target for influenza vaccination in the population group aged 65 years and older is 75%. 
 
Commentary  
 Figure 5 shows the national trend over the last ten years since 2004. This data shows that 
although the target of 75% has not been reached, there was a peak in 2008 at 70% 
followed by a reduction. Since 2011 rates have increased.  (Data for 2013 are provisional 
and data for 2014 were not available at time of publication). 
 Figure 6 shows Irelands uptake is below the average for OECD countries. 
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Figure 5: Immunisation against influenza in medical card and GP visit card holders aged 65 and over, Ireland, 
2004-2013 
 
Source: Health Protection Surveillance Centre (HPSC)             
Notes: Data for 2013 are provisional. 
Data for 2013 refers to the 2013/2014 influenza season, 2012 refer to the 2012/2013 influenza season etc. 
 
Figure 6: Immunisation against influenza, population aged 65 and over for selected OECD countries, 2005 & 
2011 (or nearest year) 
 
Source: OECD Health Statistics 
Note on international comparability: The main limitation in terms of data comparability arises from the use of 
different data sources, whether survey or programme, which are susceptible to different types of errors and 
biases. For example, data from population surveys may reflect some variation due to recall errors and 
irregularity of administration. 
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Cancer Screening Rates 
Screening rate for breast cancer   
 
Description 
Percentage uptake of breast screening in Ireland by eligible* women in the population 
between 2004 - 2013 
 
Rationale for selection of indicator  
Breast cancer is the most common form of cancer in women. One in nine women will 
develop breast cancer at some point in their life and one in thirty will die from the disease.  
In Ireland “BreastCheck” invites women between the ages of 50 and 65 years (age range 
extending to 69 years in 2015) for a mammogram every two years. The target uptake rate in 
Ireland is 70%.  
 
Commentary 
 The uptake of breast screening by those eligible has remained above the target of 
70%. However, there has been a decline over the last number of years (Figure 7). The 
reason for this downward trend needs to be further explored.  
 Figure 8 shows that Ireland‟s rate of uptake for breast screening is higher than the 
OECD20 average. However, it should be noted that there may be differences in 
scheduling and eligibility for breast screening programmes in different countries and 
this needs to be taken into account in comparing uptake levels for screening 
programmes.  
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Figure 7: Percentage uptake of breast screening of the eligible
*
 population, Ireland, 2004-2013 
 
Source: National Screening Service 
Notes: 
* The eligible population refers to the known target population (women of screening age that are known to 
the programme) less those women excluded or suspended by the programme based on certain eligibility 
criteria. See Appendix 3 for further details.  
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Figure 8: Breast screening in women aged 50 – 69 in OECD countries, 2001 & 2011 (or nearest year) 
 
Source: OECD Health Statistics 
1. Programme, 2. Survey, * Three-year average 
Note on international comparability: Screening rates reflect the proportion of women who are eligible for a 
screening test and actually receive the test. Some countries ascertain screening based on surveys and other 
based on encounter data, which may influence the results. Survey-based results may be affected by recall bias. 
Programme data are often calculated for monitoring national screening programmes, and differences in target 
population and screening frequency may also lead to variations in screening coverage across countries. 
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Screening rate for cervical cancer 
 
Description 
The proportion of the eligible population in Ireland who had a satisfactory smear test within a  
five year time period.   
 
Rationale for selection of indicator  
Cervical cancer is highly preventable if pre-cancerous changes are detected and treated before 
progression occurs.  
 
In Ireland all women aged 25-60 years are able to avail of CervicalCheck. The programme 
operates both an invitation entry system whereby eligible women received an invitation letter 
and “direct entry” whereby a woman can be screened by a smear taker (GP). CervicalCheck 
aims to reach a target five year coverage of 80%. In the first five years of the programme 
between 1
st
 September 2008 and 31
st
 August 2013, 331 790 women attended screening.  
 
Commentary 
 The coverage of CervicalCheck in the first five years was 75% (2008-2013). Coverage by 
age group is shown in Figure 9 which shows higher coverage in the younger compared to 
the older age groups. 
 Figure 10 shows that Ireland‟s rate of uptake for cervical screening is higher than the 
OECD24 average. However, it should be noted that there may be differences in 
scheduling and eligibility for cervical screening programmes in different countries and 
this needs to be taken into account in comparing uptake levels for screening programmes.  
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Figure 9: The coverage in the first five years of the cervical screening programme in Ireland by age group, 
01/09/2008-31/08/2013 
 
Source: National Screening Service 
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Figure 10: Cervical screening in women aged 20 – 69 in OECD countries, 2001 & 2011 (or nearest year)
 
Source: OECD Health Statistics 
1. Programme, 2. Survey, * Three-year average 
Note on international comparability: Screening rates reflect the proportion of women who are eligible for a 
screening test and actually receive the test. Some countries ascertain screening based on surveys and other 
based on encounter data, which may influence the results. Survey-based results may be affected by recall bias. 
Programme data are often calculated for monitoring national screening programmes, and differences in target 
population and screening frequency may also lead to variations in screening coverage across countries. 
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Domain 2: Supporting People with Long Term Conditions 
 
Ambulatory Care Sensitive Conditions 
 COPD hospitalisation rates 
 Asthma hospitalisation rates 
 Diabetes hospitalisation rates 
 
COPD Hospitalisation Rates 
 
Description 
The age and sex standardised rate of hospitalisations of people aged 15 years and older with a 
principal diagnosis of COPD per 100,000 population.  
 
Rationale for selection of indicator 
Chronic obstructive pulmonary disease (COPD) is a common progressive lung disease that 
almost exclusively affects current or prior smokers. Symptoms of COPD can usually be 
managed by the patient with their GP and the primary care team, only requiring 
hospitalisation if they have very severe symptoms. It is important to note that not all 
hospitalisations are avoidable and they may be clinically appropriate.  
 
Commentary:  
 The national age-sex standardised hospitalisation rate for COPD has increased slightly 
between 2005 and 2013, with 378 hospitalisations per 100,000 population in 2005 
compared to 393 per 100,000 population in 2013 (Figure 11). Most countries in the 
OECD have reported a reduction in hospitalisation rates for COPD over recent years 
which the OECD proposes may represent an improvement in access to, and the 
quality of primary care (23).  
 In 2011 (the latest year for which OECD data are currently available), the age-sex 
standardised hospitalisation rate for Ireland based on the OECD age-sex 
standardisation was 365.0 per 100,000 population, which was higher than the OECD 
average of 197.3 hospitalisations per 100,000 population (Figure 12), and was the 
second highest rate among selected OECD countries. Other countries that use ICD-
10-AM coding were also above the OECD average and there has been some 
discussion about the impact of different classification systems on the data and 
therefore, on the comparability of data between countries.  
38 | P a g e                  NHQRS Annual Report                                
 
 In Ireland during the three year period from 2011-2013, the hospitalisation rate by 
county of residence ranged from 219.6 in Kerry, to 657.7 hospitalisations per 100,000 
population in Offaly, a three-fold variation. (Figure 13, Table 2). The reasons behind 
this three-fold variation need to be further explored and explained. There can be a 
number of different reasons behind these variations and it cannot be concluded that 
higher or lower rates are a reflection on the quality of care provided in primary and 
community care. The reasons include, but are not limited to issues related to the 
quality of the data, differences in the prevalence of chronic conditions in the 
population, availability of services at primary and community care level, access to 
specific treatments, and the availability of hospital beds.  
 
Figure 11: COPD hospitalisation rates per 100,000 population, 2005 – 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
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Figure 12: COPD hospitalisation rates per 100,000 population for selected OECD countries, 2011 (or nearest 
year) 
 
Source: OECD Health Statistics 
Note on international comparability: Differences in coding practices among countries and the definition of an admission 
may affect the comparability of data. Differences in disease classification systems, for example between ICD-9-CM and ICD-
10-AM, may also affect data comparability. 
 
Figure 13: COPD hospitalisation rates per 100,000 population by county of residence, 2011 – 2013 
 
Source: Hospital Inpatient Enquiry (HIPE)  
Notes: Data refer to the average annual age-sex standardised hospitalisation rate per 100,000 population from 2011-2013. 
See Table 2 for 95% confidence limits. 
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Table 2: COPD hospitalisation rates per 100,000 population by county of residence, 2011 - 2013 
County of 
Residence 
Number of 
Hospitalisations 
Age-sex 
Standardised 
Hospitalisations 
Rate 
Lower 95% 
Confidence Limit 
for Rate 
Upper 95% 
Confidence Limit 
for Rate 
Carlow 539 500.8 458.7 543.0 
Cavan 782 512.7 476.8 548.5 
Clare 1,147 467.5 440.5 494.5 
Cork 2,991 276.5 266.6 286.4 
Donegal 1,719 470.3 448.2 492.5 
Dublin 9,221 378.2 370.5 385.9 
Galway 1,833 370.3 353.4 387.2 
Kerry 772 219.6 204.1 235.1 
Kildare 1,263 415.7 392.2 439.2 
Kilkenny 680 334.3 309.2 359.4 
Laois 699 487.0 451.1 523.0 
Leitrim 274 330.8 291.6 369.9 
Limerick 1,691 420.9 400.8 440.9 
Longford 416 509.1 460.6 557.7 
Louth 885 390.4 364.7 416.1 
Mayo 1,422 431.1 408.8 453.4 
Meath 879 298.3 278.3 318.4 
Monaghan 494 388.2 354.2 422.2 
Offaly 1,015 657.7 617.5 697.9 
Roscommon 597 365.1 335.8 394.3 
Sligo 600 389.4 358.5 420.3 
Tipperary 1,702 464.8 442.8 486.7 
Waterford 768 308.5 286.7 330.3 
Westmeath 943 557.6 522.3 592.9 
Wexford 1,456 473.9 449.5 498.3 
Wicklow 804 311.7 289.9 333.4 
National Total 35,592 385.3 381.3 389.3 
Source: Hospital Inpatient Enquiry (HIPE) 
 
Notes:  
Data refer to the average annual age-sex standardised hospitalisations rate per 100,000 population from 2011-
2013. 
See Appendix 3 for detailed indicator definitions and methodology.  
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Asthma Hospitalisation Rates 
 
Description  
The age and sex standardised rate of hospitalisations of people aged 15 years and older with a 
principal diagnosis of asthma per 100,000 population.  
 
Rationale for selection of indicator  
Asthma is a common condition which causes difficulty breathing. For most people with 
asthma it is possible to improve their health and quality of life so that they have few or no 
symptoms (asthma control). Hospitalisation with an acute exacerbation (attack) of asthma is a 
sign of uncontrolled asthma, and so, in many cases, may be preventable. One of the aims of 
good asthma healthcare is to reduce the need for hospitalisation with better preventive 
healthcare. It is important to note that not all hospitalisations are avoidable and they may be 
clinically appropriate.   
 
Commentary 
 The national trend in relation to hospitalisations for asthma over the last several years 
until 2013 has been decreasing (Figure 14). The age-sex standardised rate of 
hospitalisations for asthma has decreased from 55 per 100,000 population in 2005 to 
41 per 100,000 population in 2013, a reduction of 25%.  
 In 2011 (the latest year for which OECD data are currently available), the age-sex 
standardised hospitalisation rate for Ireland was 36.8 hospitalisations per 100,000 
population which was below the OECD average of 47.4 hospitalisations per 100,000 
population (Figure 15).  
 During the three year period from 2011-2013, the rate by county of residence ranged 
from 21.2 in Monaghan to 78.6 hospitalisations per 100,000 population in Longford, 
an almost four-fold variation (Figure 16, Table 3). The reasons behind this variation 
need to be further explored and explained. There can be a number of different reasons 
behind these variations and it cannot be concluded that higher or lower rates are a 
reflection on the quality of care provided in primary and community care. The reasons 
include, but are not limited to, issues related to the quality of the data, differences in 
the prevalence of chronic conditions in the population, availability of services at 
primary and community care level, access to specific treatments and the availability 
of hospital beds.  
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Figure 14: Asthma hospitalisations rates per 100,000 population, 2005 – 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
 
Figure 15: Asthma hospitalisation rates per 100,000 population for selected OECD countries, 2011 (or 
nearest year) 
 
Source: OECD Health Statistics 
Note on international comparability: Differences in coding practices among countries and the definition of an 
admission may affect the comparability of data. Differences in disease classification systems, for example 
between ICD-9-CM and ICD-10-AM, may also affect data comparability. 
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Figure 16: Asthma hospitalisations rates per 100,000 population by county of residence, 2011 – 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
 
Notes:  
Data refer to the average annual age-sex standardised admission rate per 100,000 population from 2011-2013. 
See Table 3 for 95% confidence limits. 
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Table 3: Asthma hospitalisation rates per 100,000 population by county of residence, 2011 – 2013 
 
County of 
Residence 
Number of 
Hospitalisations 
Age-sex 
Standardised 
Hospitalisation 
Rate 
Lower 95% 
Confidence Limit 
for Rate 
Upper 95% 
Confidence Limit 
for Rate 
Carlow 52 43.8 31.8 55.8 
Cavan 91 56.0 44.4 67.6 
Clare 132 48.6 40.2 57.0 
Cork 359 30.1 27.0 33.2 
Donegal 200 55.5 47.8 63.2 
Dublin 1,130 39.0 36.7 41.4 
Galway 238 43.0 37.5 48.5 
Kerry 97 28.4 22.7 34.1 
Kildare 155 34.2 28.6 39.9 
Kilkenny 65 29.2 22.1 36.4 
Laois 93 51.1 40.5 61.6 
Leitrim 27 38.6 23.7 53.4 
Limerick 221 50.0 43.4 56.7 
Longford 72 78.6 60.3 96.8 
Louth 95 35.6 28.4 42.8 
Mayo 131 42.7 35.4 50.1 
Meath 115 29.4 23.8 35.0 
Monaghan 29 21.2 13.4 28.9 
Offaly 52 27.7 20.2 35.3 
Roscommon 50 33.9 24.4 43.4 
Sligo 60 38.3 28.6 48.0 
Tipperary 201 55.2 47.5 62.8 
Waterford 103 38.2 30.8 45.6 
Westmeath 135 69.9 58.0 81.8 
Wexford 132 39.8 32.9 46.6 
Wicklow 133 43.5 36.0 51.0 
National Total 4,168 39.9 38.7 41.2 
 
Source: Hospital Inpatient Enquiry (HIPE) 
 
Notes:  
Data refer to the average annual age-sex standardised hospitalisation rate per 100,000 population from 2011-
2013. 
See Appendix 3 for detailed indicator definitions and methodology.  
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Diabetes Hospitalisation Rates 
 
Description 
The age and sex standardised rate of hospitalisations of people aged 15 years and older with a 
principal diagnosis of diabetes per 100,000 population.  
 
Rationale for selection of indicator 
Diabetes is a condition where the body cannot regulate excessive glucose levels in the blood. 
This can lead to many complications over the longer term such as kidney failure or loss of 
sight; in the shorter term, loss of consciousness or coma can occur.  
 
Patients with diabetes may be hospitalised for diabetic complications such as unstable 
diabetes, hypoglycaemia, hyperglycaemia or diabetic coma. It is important to note that not all 
hospitalisations are avoidable and they may be clinically appropriate.  
 
Commentary 
 The national age-sex standardised hospitalisation rate for diabetes has decreased by 
20% between 2005 and 2013, with 173 hospitalisations per 100,000 population in 
2005 compared to 138 per 100,000 population in 2013 (Figure 17).  
 In 2011 (the latest year for which OECD data are currently available), the age-sex 
standardised hospitalisation rate for Ireland was 135.3 hospitalisations per 100,000 
population which was below the OECD average of 171.9 hospitalisations per 100,000 
population (Figure 18).  
 During the three year period from 2011-2013, the rate of hospitalisations by county of 
residence ranged from 101.7 in Leitrim, to 199.0 per 100,000 population in Carlow, 
almost a two-fold variation (Figure 19, Table 4). The reasons behind this variation 
need to be further explored and explained. There can be a number of different reasons 
behind these variations and it cannot be concluded that higher or lower rates are a 
reflection on the quality of care provided in primary and community care. The reasons 
include, but are not limited to, issues related to the quality of the data, differences in 
the prevalence of chronic conditions in the population, availability of services at 
primary and community care level, access to specific treatments and the availability 
of hospital beds.  
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Figure 17: Diabetes hospitalisation rates per 100,000 population, 2005 – 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
 
Figure 18: Diabetes hospitalisation rates per 100,000 population for selected OECD countries, 2011 (or 
nearest year) 
 
Source: OECD Health Statistics 
Note on international comparability: Differences in coding practices among countries and the definition of an 
admission may affect the comparability of data. Differences in disease classification systems, for example 
between ICD-9-CM and ICD-10-AM, may also affect data comparability. 
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Figure 19: Diabetes hospitalisation rates per 100,000 population by county of residence, 2011 – 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
 
Notes:  
Data refer to the average annual age-sex standardised rate of hospitalisations per 100,000 population from 
2011-2013. 
See Table 4 for 95% confidence limits. 
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Table 4: Diabetes hospitalisation rates per 100,000 population by county of residence, 2011 - 2013 
County of 
Residence 
Number of 
Hospitalisations 
Age-sex 
Standardised 
Hospitalisations 
Rate 
Lower 95% 
Confidence Limit 
for Rate 
Upper 95% 
Confidence Limit 
for Rate 
Carlow 227 199.0 172.9 225.1 
Cavan 316 193.7 172.2 215.2 
Clare 383 145.3 130.7 159.9 
Cork 1,440 126.3 119.7 132.8 
Donegal 532 145.8 133.3 158.2 
Dublin 3,182 121.4 117.1 125.6 
Galway 705 134.3 124.3 144.3 
Kerry 492 140.9 128.4 153.4 
Kildare 632 178.1 163.5 192.7 
Kilkenny 320 154.3 137.3 171.3 
Laois 214 135.4 116.9 153.9 
Leitrim 83 101.7 79.5 123.8 
Limerick 613 146.4 134.7 158.0 
Longford 138 161.7 134.5 188.8 
Louth 379 149.9 134.6 165.2 
Mayo 379 117.8 105.9 129.8 
Meath 515 152.1 138.4 165.8 
Monaghan 225 167.6 145.7 189.6 
Offaly 257 151.5 132.8 170.1 
Roscommon 199 126.9 109.1 144.6 
Sligo 237 149.1 130.1 168.1 
Tipperary 617 164.6 151.6 177.7 
Waterford 455 175.6 159.4 191.8 
Westmeath 334 177.0 157.9 196.1 
Wexford 535 166.7 152.5 180.9 
Wicklow 495 164.8 150.0 179.5 
National Total 13,904 140.8 138.5 143.2 
 
Source: Hospital Inpatient Enquiry (HIPE) 
 
Notes:  
Data refer to the average annual age-sex standardised admission rate per 100,000 population from 2011-2013. 
See Appendix 3 for detailed indicator definitions and methodology.  
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Domain 3: Helping people when they are being treated and cared 
for in our health services 
 
Cancer Survival Rates 
 Breast cancer survival rates 
 Cervical cancer survival rates 
 Colorectal cancer survival rates 
 
Acute Hospital Care 
 In-hospital mortality within 30 days after acute myocardial infarction (AMI) 
 In-hospital mortality within 30 days after haemorrhagic stroke  
 In-hospital mortality within 30 days after ischaemic stroke In-hospital waiting 
time for hip fracture surgery 
 Caesarean section rate 
 
 
Cancer Survival Rates 
Breast cancer survival rates 
 
Description 
Age-standardised estimates of cumulative 5-year relative survival in Ireland for female breast 
cancer patients for the period 2005-2010 
 
Rationale for selection of indicator  
Breast cancer survival reflects advances in treatments, as well as public health interventions 
to detect the disease early through screening programmes and greater awareness of the 
disease. The introduction of new evidence based treatment regimens and screening 
programmes has improved the survival for breast cancer in the last few years, as well as 
improving quality of life for survivors. 
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Commentary 
 Figure 20 shows breast cancer 5-year relative survival rates nationally, and for HSE 
regions for the period 2005-2010. There is no statistically significant difference 
between the national rate and any of the four regions.  
 Figure 21 shows that the survival rate in Ireland is below the OECD average but has 
improved over time. The findings at national level are compared with other countries 
in the OECD. It is important to note that there may be variations between countries 
due to difference in their coding practices, in the definitions and disease classification 
systems used and therefore, this needs to be taken into account when comparing the 
countries.     
Figure 20: Age-standardised estimates of cumulative 5-year relative survival in Ireland for female breast 
cancer patients for the period 2005-2010 
 
Source: National Cancer Registry of Ireland 
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Figure 21: Breast cancer five-year relative survival, 2001-2006 and 2006-2011 (or nearest period), OECD 
countries  
 
Source: OECD Health Statistics. 
Notes: 95% confidence intervals represented by H. 
1. Period analysis. 2. Cohort analysis. * Three-period average. 
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Cervical cancer survival rates 
 
Description 
Age-standardised estimates of cumulative 5-year relative survival in Ireland for cervical 
cancer patients for the period 2005-2010 
 
Rationale for selection of indicator  
In recent years, five-year relative survival for cervical cancer has improved in many 
countries. This may be due to many reasons including improved effectiveness of screening 
and treatment. 
 
Commentary 
 
 Figure 22 shows cervical cancer 5-year relative survival rates nationally, and for HSE 
regions for the period 2005-2010. There is no statistically significant difference 
between the national rate and any of the 4 regions.   
 Figure 23 shows that the survival rate in Ireland is below the OECD average and has 
decreased over time, although this reduction is not statistically significant. The 
findings at national level are compared with other countries in the OECD. It is 
important to note that there may be variations between countries due to difference in 
their coding practices, in the definitions and disease classification systems used and 
therefore, this needs to be taken into account when comparing the countries.     
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Figure 22: Age-standardised estimates of cumulative 5-year relative survival in Ireland for cervical cancer 
patients for the period 2005-2010 
 
Source: National Cancer Registry of Ireland 
 
Figure 23: Cervical cancer five-year relative survival, 2001-2006 and 2006-2011 (or nearest period), OECD 
countries 
 
Source: OECD Health Statistics. 
Notes: 95% confidence intervals represented by H. 
1. Period analysis. 2. Cohort analysis. * Three-period average. 
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Colorectal Cancer survival rates 
 
Description 
Age-standardised estimates of cumulative 5-year relative survival in Ireland for colorectal 
cancer patients for the period 2005-2010. 
 
Rationale for selection of indicator 
Advances in diagnosis and treatment of colorectal cancer have increased survival over the 
last decade. There is compelling evidence in support of the clinical benefit of improved 
surgical techniques, radiation therapy and combined chemotherapy, with most countries in 
the OECD showing improvement in survival over recent periods. 
 
Commentary 
 Figure 24 shows colorectal cancer survival rates nationally and for the HSE regions 
for the period 2005 to 2010. This shows survival rates are lowest in the West region 
although this is not a statistically significant difference from the national rate.  
 In Figure 25 the survival rates at national level are compared with other countries in 
the OECD. Ireland is below the OECD five year survival rate although it does 
increase between the time periods presented.  It is important to note that there may be 
variations between countries due to difference in their coding practices, in the 
definitions and disease classification systems used and therefore, this needs to be 
taken into account when comparing the countries.    
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Figure 24: Age-standardised estimates of cumulative 5-year relative survival in Ireland for colorectal cancer 
patients for the period 2005-2010 
 
Source: National Cancer Registry of Ireland 
 
Figure 25: Colorectal cancer five-year relative survival, 2001-2006 and 2006-2011 (or nearest 
period), OECD countries
 
Source: OECD Health Statistics. 
Notes: 95% confidence intervals represented by I-I. 
1. Period analysis. 2. Cohort analysis. * Three-period average. 
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Acute Hospital Care 
In-hospital mortality within 30 days after Acute Myocardial Infarction (AMI)  
 
Description 
In-hospital mortality within 30 days after AMI is defined as the number of patients aged 45 
and over who die in hospital within 30 days of being admitted with a principal diagnosis of 
an AMI, as a proportion of the total number of patients aged 45 and over admitted to that 
hospital with a principal diagnosis of an AMI.  
 
Rationale for selection of indicator  
A heart attack, or acute myocardial infarction (AMI), is one of the leading causes of death in 
Ireland. Heart attacks are life-threatening emergencies that happen when the coronary 
arteries, the blood vessels supplying blood to the heart muscle, are suddenly blocked. Lack of 
blood damages the heart muscle, weakening its function or stopping it altogether. Evidence 
links the processes of care for AMI, such as thrombolysis and early treatment with aspirin 
and beta-blockers, to survival improvements. The use of the 30-day mortality rate after AMI 
is a recognised outcome measure of acute care quality, and is one of the OECD Health Care 
Quality Indicators (HCQI).  
 
Commentary 
 Figure 26 shows the national trend in mortality rates following a heart attack over the 
last 10 years (2004 to 2013). Between 2004 and 2013, there has been a 40% reduction 
in in-hospital mortality rates within 30 days of admission for an AMI (from 10.7 
deaths per 100 cases in 2004 to 6.4 in 2013).  
 The average in-hospital mortality rate in the 30 days following admission to hospital 
for AMI in Ireland is lower than the OECD average rate, i.e. 6.8 deaths per 100 cases 
in Ireland, compared to the OECD average of 7.9 deaths per 100 cases (Figure 27).  
 Reviewing the three year period from 2011-2013, it was found that in most hospitals 
the age-sex standardised mortality rates were within or lower than the expected range. 
However, the age-sex standardised mortality rates for three hospitals were statistically 
significantly higher than the national rate at the 95% confidence level (Table 5, Figure 
28). Note, that for this indicator, the age-sex standardised mortality rates are 
statistically significantly higher than the national rate if the lower 95% confidence 
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limit for a hospital is above the upper 95% confidence limit for the national rate (i.e. 
above 7.05).  
 It is important to note however, that the age-sex standardised rates presented here are 
high level indicators only. There can be many reasons why the age-sex standardised 
mortality rates for a hospital would be higher or lower rates than the national average, 
including  
a. differences in the types of patients attending different hospitals (for example some 
hospitals may have  a higher or lower proportion of patients with other medical 
conditions attending than others and this may influence outcomes),  
b. inconsistencies in the quality of the data gathered in different hospitals, 
c. differences in access to medical care prior to arrival at the hospital,  
d. transfer patterns of patients between different hospitals,  
e. variations in the quality of care delivered in different hospitals. 
  Therefore, it cannot be concluded that a high mortality rate is indicative of poor 
quality care. Rather it provides an indication that a further evaluation should be 
carried out to determine the reasons for the identified variation.  
Figure 26: In-hospital mortality within 30 days of admission for AMI, 2004 - 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
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Figure 27: In-hospital mortality within 30 days of admission for AMI for selected OECD countries, 2011 (or 
nearest year) 
 
Source: OECD Health Statistics. 
Note: 95% confidence intervals represented by H. 
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Figure 28: In-hospital mortality within 30 days of admission for AMI, 2011 - 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
Notes:  
Hospitals with small numbers of cases tend to have unstable rates and wider confidence intervals. For this report rates are 
not displayed for hospitals with less than 100 cases, although the data for these hospitals have been included in the 
calculation of the national rates.  However some hospitals with more than 100 cases may still have unstable rates and 
caution should be exercised in interpreting rates with wide confidence intervals.  
The data presented above are age-sex standardised mortality rates per 100 cases. 95% confidence intervals for hospitals 
and hospital groups are shown by H.  
Where the 95% confidence interval for a hospital or hospital group overlaps the 95% confidence interval of the national 
rate (i.e. the dashed green lines), it can be concluded that the rate is not statistically significantly different from the 
national rate and so is within the expected range.  
Where the 95% confidence interval for a hospital or hospital group does not overlap the confidence interval of the national 
rate, it implies that the mortality rate is statistically significantly different from the national rate and is therefore outside 
the expected range.  
There can be many reasons for variations in mortality rates including differences in patient profiles; data quality issues; and 
differences in the quality of care.  
Age-sex standardised mortality rates that are statistically significantly higher at the 95% confidence level than the national 
rate are shown in amber. Rates for all other hospitals and hospital groups are below or within the expected range of the 
national rate.   
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Table 5: In-hospital mortality within 30 days of admission for AMI, 2011 – 2013 
Hospital Group 
Number of 
Cases 
Age-sex 
Standardised 
Death Rate 
(ASDR) per 
100 Cases 
Lower 95% 
Confidence 
Limit for 
ASDR 
Upper 95% 
Confidence 
Limit for 
ASDR 
Ireland East  5090 6.15 5.46 6.84 
Mater Misericordiae University Hospital 1933 3.96 2.9 5.02 
St. Vincent’s University Hospital 871 5.69 4.14 7.24 
St. Luke’s Hospital Kilkenny 828 8.86 6.9 10.82 
Wexford General Hospital 649 6.03 4.12 7.94 
Our Lady’s Hospital Navan 359 5.06 2.83 7.29 
Midland Regional Hospital Mullingar 228 8.88 5.36 12.39 
St. Columcille’s Hospital 160 8.8 5.26 12.34 
St. Michael’s Hospital 62 - - - 
Dublin Midlands  2347 7.4 6.26 8.54 
St. James's Hospital 840 7.08 5.27 8.9 
Tallaght Hospital 712 6.08 3.8 8.36 
Naas General Hospital 322 7.47 4.63 10.31 
Midland Regional Hospital Tullamore 265 11.96 8.29 15.63 
Midland Regional Hospital Portlaoise 208 3.84 0.43 7.24 
RCSI Hospitals  2257 8.01 6.89 9.12 
Our Lady of Lourdes Hospital Drogheda 695 6.3 4.51 8.1 
Beaumont Hospital 684 7.13 5.12 9.14 
Connolly Hospital Blanchardstown 483 9.87 7.18 12.55 
Cavan General Hospital 395 10.36 7.51 13.2 
UL Hospitals 1229 5.84 4.58 7.11 
University Hospital Limerick 990 6.49 4.96 8.02 
Nenagh Hospital 119 5.23 1.69 8.77 
Ennis Hospital 66 - - - 
St. Johns Hospital 54 - - - 
South / South West  3942 6.02 5.24 6.8 
Cork University Hospital 1586 6.3 4.93 7.68 
University Hospital Waterford 964 4.47 2.99 5.95 
South Tipperary General Hospital 436 6.98 4.74 9.22 
Kerry General Hospital 399 4.12 2.16 6.08 
Mercy University Hospital Cork 276 8.38 5.03 11.73 
Mallow General Hospital 135 6.34 2.94 9.74 
South Infirmary/Victoria University Hospital Cork 77 - - - 
Bantry General Hospital 69 - - - 
Saolta University Health Care 3511 7.2 6.38 8.02 
Galway University Hospitals 1212 7.57 6.05 9.08 
Mayo General Hospital 876 8.23 6.57 9.89 
Letterkenny General Hospital 643 7.58 5.67 9.49 
Sligo General Hospital 488 5.39 3.52 7.26 
Portiuncula Hospital Ballinasloe 286 5.99 3.37 8.61 
Roscommon County Hospital 6 - - - 
Total for All Hospitals 18376 6.68 6.32 7.05 
Source: Hospital Inpatient Enquiry (HIPE) 
 
Notes: Hospitals with small numbers of cases tend to have unstable rates and wider confidence intervals. For 
this report rates are not displayed for hospitals with less than 100 cases, although the data for these hospitals 
have been included in the calculation of the national rates.  However some hospitals with more than 100 cases 
may still have unstable rates and caution should be exercised in interpreting rates with wide confidence 
intervals.  
See Appendix 3 for detailed indicator definitions and methodology.  
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In-hospital mortality within 30 days after haemorrhagic stroke  
Description 
In-hospital mortality within 30 days after haemorrhagic stroke is defined as the number of 
patients aged 45 and over who die in hospital within 30 days of being admitted to hospital 
with a principal diagnosis of haemorrhagic stroke, as a proportion of the total number of 
patients aged 45 and over admitted to that hospital with a principal diagnosis of haemorrhagic 
stroke.  
 
Rationale for selection of indicator  
Stroke is a leading cause of mortality in Ireland. A stroke is the sudden death of brain cells in 
a localized area due to inadequate blood flow caused by a haemorrhage (bleed) or ischaemia 
(clot). Many patients who survive a stroke are left with disability. Timely diagnosis and 
therapy for all stroke victims in dedicated stroke units improves survival and limits disability. 
Variations in stroke mortality rates reflect many factors including early recognition of 
symptoms, seeking medical care as quickly as possible, and potential differences in the care 
provided.  
 
Commentary 
 The age-sex standardised in-hospital mortality rate within 30 days of admission for 
haemorrhagic stroke has remained almost unchanged over the ten year period from 
2004 to 2013, with 24.4 deaths per 100 cases in 2004 compared to 24.6 in 2013 
(Figure 29).  
 In 2011, the average in-hospital mortality rate within 30 days of admission with 
haemorrhagic stroke in Ireland was above the OECD average rate, i.e. 26.2 deaths per 
100 cases for Ireland in that year compared to the OECD average of 22.6 deaths per 
100 cases (Figure 30).  
 During the three year period from 2011-2013, the age-sex standardised mortality rate 
for one hospital was statistically significantly higher than the national rate at the 95% 
confidence level. The rates for all other hospitals were within or lower than the 
expected range (Table 6, Figure 31). The overall rate for one hospital group (Ireland 
East) was also statistically significantly higher than the national rate. Note, that for 
this indicator, the age-sex standardised mortality rates are statistically significantly 
higher than the national rate if the lower 95% confidence limit for a hospital or a 
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hospital group is above the upper 95% confidence limit for the national rate (i.e. 
above 26.0).  
 It is important to note however, that the age-sex standardised rates presented here are 
high level indicators only. There can be many reasons why a hospital would have 
higher or lower rates than the national average, including  
a. differences in the types of patients attending different hospitals (for example, 
some hospitals may have  a higher or lower proportion of patients with other 
medical conditions attending than others, and this may influence outcomes),  
b. inconsistencies in the quality of the data gathered in different hospitals, 
c. differences in access to medical care prior to arrival at the hospital,  
d. transfer patterns of patients between different hospitals,  
e. variations in the quality of care delivered in different hospitals. 
 It cannot be concluded that a high mortality rate for a particular hospital is indicative 
of poor quality care. Rather it provides an indication that a further evaluation should 
be carried out to determine the reasons for the identified variation in mortality rates.  
 
Figure 29: In-hospital mortality within 30 days of admission for haemorrhagic stroke, 2004 - 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
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Figure 30: In-hospital mortality within 30 days of admission for haemorrhagic stroke for selected OECD 
countries, 2011 (or nearest year) 
 
Source: OECD Health Statistics. 
Note: 95% confidence intervals represented by H. 
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Figure 31: In-hospital mortality within 30 days of admission for haemorrhagic stroke, 2011 - 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
Notes:  
Hospitals with small numbers of cases tend to have unstable rates and wider confidence intervals. For this report rates are 
not displayed for hospitals with less than 100 cases, although the data for these hospitals have been included in the 
calculation of the national rates.  However some hospitals with more than 100 cases may still have unstable rates and 
caution should be exercised in interpreting rates with wide confidence intervals.  
The data presented above are age-sex standardised mortality rates per 100 cases. 95% confidence intervals for hospitals 
and hospital groups are shown by H.  
Where the 95% confidence interval for a hospital or hospital group overlaps the 95% confidence interval of the national 
rate (i.e. the dashed green lines), it can be concluded that the rate is not statistically significantly different from the 
national rate and so is within the expected range.  
Where the 95% confidence interval for a hospital or hospital group does not overlap the confidence interval of the national 
rate, it implies that the mortality rate is statistically significantly different from the national rate and is therefore outside 
the expected range.  
There can be many reasons for variations in mortality rates including differences in patient profiles; data quality issues; and 
differences in the quality of care.  
Age-sex standardised mortality rates that are statistically significantly higher at the 95% confidence level than the national 
rate are shown in amber. Rates for all other hospitals and hospital groups are below or within the expected range of the 
national rate.   
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Table 6: In-hospital mortality within 30 days of admission for haemorrhagic stroke, 2011 – 2013 
Hospital Group 
Number of 
Cases 
Age-sex 
Standardised 
Death Rate 
(ASDR) per 
100 Cases 
Lower 95% 
Confidence 
Limit for 
ASDR 
Upper 95% 
Confidence 
Limit for 
ASDR 
Ireland East  849 30.23 27.17 33.29 
St. Vincent’s University Hospital 255 28.74 23.31 34.17 
Mater Misericordiae University Hospital 199 31.25 25.04 37.47 
Midland Regional Hospital Mullingar 113 33.18 25.21 41.16 
St. Luke’s Hospital Kilkenny 85 - - - 
Wexford General Hospital 84 - - - 
Our Lady’s Hospital Navan 65 - - - 
St. Columcille’s Hospital 42 - - - 
St. Michael’s Hospital 6 - - - 
Dublin Midlands  486 28.11 24.13 32.09 
St. James's Hospital 157 27.71 21.51 33.91 
Tallaght Hospital 136 20.15 13.36 26.93 
Naas General Hospital 111 36.24 28.01 44.47 
Midland Regional Hospital Tullamore 41 - - - 
Midland Regional Hospital Portlaoise 41 - - - 
RCSI Hospitals  1309 16.45 14.32 18.59 
Beaumont Hospital 1002 11.91 9.65 14.18 
Our Lady of Lourdes Hospital Drogheda 134 29.75 22.53 36.98 
Cavan General Hospital 112 13.4 8.13 18.68 
Connolly Hospital Blanchardstown 61 - - - 
UL Hospitals 217 26.07 20.17 31.98 
University Hospital Limerick 165 30.11 23.31 36.91 
Ennis Hospital 20 - - - 
Nenagh Hospital 20 - - - 
St. Johns Hospital 12 - - - 
South / South West  913 26.82 23.98 29.66 
Cork University Hospital 479 25.74 21.72 29.75 
Kerry General Hospital 146 31.53 23.98 39.07 
University Hospital Waterford 114 28.1 20.54 35.66 
South Tipperary General Hospital 76 - - - 
Mercy University Hospital Cork 61 - - - 
Bantry General Hospital 22 - - - 
South Infirmary/Victoria University Hospital Cork 9 - - - 
Mallow General Hospital 6 - - - 
Saolta University Health Care 593 27.42 23.85 30.98 
Galway University Hospitals 217 26.62 21.02 32.22 
Mayo General Hospital 113 31.11 23.49 38.72 
Sligo General Hospital 110 28.44 20.24 36.64 
Letterkenny General Hospital 97 - - - 
Portiuncula Hospital Ballinasloe 48 - - - 
Roscommon County Hospital 8 - - - 
Total for All Hospitals 4367 24.74 23.47 26.00 
Source: Hospital Inpatient Enquiry (HIPE) 
 
Notes: Hospitals with small numbers of cases tend to have unstable rates and wider confidence intervals. For 
this report rates are not displayed for hospitals with less than 100 cases, although the data for these hospitals 
have been included in the calculation of the national rates.  However some hospitals with more than 100 cases 
may still have unstable rates and caution should be exercised in interpreting rates with wide confidence 
intervals.  
See Appendix 3 for detailed indicator definitions and methodology.  
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In-hospital mortality within 30 days after ischaemic stroke  
Description 
In-hospital mortality within 30 days after ischaemic stroke is defined as the number of 
patients aged 45 and over who die in hospital within 30 days of being admitted to hospital 
with a principal diagnosis of ischaemic stroke, as a proportion of the total number of patients 
aged 45 and over admitted to that hospital with a principal diagnosis of ischaemic stroke.  
 
Rationale for selection of indicator  
As mentioned in the previous rationale for haemorrhagic stroke an ischaemic stroke is caused 
by death of brain cells in a localized area due to inadequate blood flow caused by ischaemia 
(blood clot).  
 
Commentary 
 The age-sex standardised in-hospital mortality rate within 30 days of admission for 
ischaemic stroke has decreased from 11.2 deaths per 100 cases in 2004 to 9.7 in 2013, a 
reduction of 13.6% (Figure 32).  
 In 2011, the average in-hospital mortality rate within 30 days of admission with 
ischaemic stroke in Ireland was above the OECD average rate, i.e. 9.9 deaths per 100 
cases for Ireland in that year compared to the OECD  average of 8.5 deaths per 100 cases 
(Figure 33).  
 During the three year period from 2011-2013, the age-sex standardised mortality rates for 
two hospitals were statistically significantly higher than the national rate at the 95% 
confidence level.  The rates for all other hospitals were within or lower than the expected 
range (Table 7 and Figure 34).  Note that for this indicator the age-sex standardised 
mortality rates are statistically significantly higher than the national rate if the lower 95% 
confidence limit for a hospital or a hospital group is above the upper 95% confidence 
limit for the national rate (i.e. above 10.25).  
 It is important to note however that the age-sex standardised rates presented here are high 
level indicators only. There can be many reasons why a hospital would have higher or 
lower rates than the national average, including 
a. differences in the types of patients attending different hospitals (for example, 
some hospitals may have  a higher or lower proportion of patients with other 
medical conditions attending than others and this may influence outcomes),  
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b. inconsistencies in the quality of the data gathered in different hospitals, 
c. differences in access to medical care prior to arrival at the hospital,  
d. transfer patterns of patients between different hospitals,  
e. variations in the quality of care delivered in different hospitals. 
 Therefore, it cannot be concluded that a high mortality rate is indicative of poor quality 
care. Rather it provides an indication that a further evaluation should be carried out to 
determine the reasons for the identified variation in mortality rates.  
 
Figure 32: In-hospital mortality within 30 days of admission for ischaemic stroke, 2004 - 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
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Figure 33: In-hospital mortality within 30 days of admission for ischaemic stroke for selected OECD 
countries, 2011 (or nearest year) 
 
Source: OECD Health Statistics. 
Note: 95% confidence intervals represented by H. 
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Figure 34: In-hospital mortality within 30 days of admission for ischaemic stroke, 2011 - 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
Notes:  
Hospitals with small numbers of cases tend to have unstable rates and wider confidence intervals. For this report rates are 
not displayed for hospitals with less than 100 cases, although the data for these hospitals have been included in the 
calculation of the national rates.  However some hospitals with more than 100 cases may still have unstable rates and 
caution should be exercised in interpreting rates with wide confidence intervals.  
The data presented above are age-sex standardised mortality rates per 100 cases. 95% confidence intervals for hospitals 
and hospital groups are shown by H.  
Where the 95% confidence interval for a hospital or hospital group overlaps the 95% confidence interval of the national 
rate (i.e. the dashed green lines), it can be concluded that the rate is not statistically significantly different from the 
national rate and so is within the expected range.  
Where the 95% confidence interval for a hospital or hospital group does not overlap the confidence interval of the national 
rate, it implies that the mortality rate is statistically significantly different from the national rate and is therefore outside 
the expected range.  
There can be many reasons for variations in mortality rates including differences in patient profiles; data quality issues; and 
differences in the quality of care.  
Age-sex standardised mortality rates that are statistically significantly higher at the 95% confidence level than the national 
rate are shown in amber. Rates for all other hospitals and hospital groups are below or within the expected range of the 
national rate.   
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Table 7: In-hospital mortality within 30 days of admission for ischaemic stroke, 2011 - 2013 
Hospital Group 
Number of 
Cases 
Age-sex 
Standardised 
Death Rate 
(ASDR) per 
100 Cases 
Lower 95% 
Confidence 
Limit for 
ASDR 
Upper 95% 
Confidence 
Limit for 
ASDR 
Ireland East  3267 9.08 8.14 10.02 
St. Vincent’s University Hospital 783 7.95 6.17 9.72 
Mater Misericordiae University Hospital 779 7.28 5.48 9.07 
Midland Regional Hospital Mullingar 403 11.79 9.02 14.57 
St. Luke’s Hospital Kilkenny 385 10.32 7.34 13.30 
Wexford General Hospital 380 10.47 7.57 13.37 
Our Lady’s Hospital Navan 298 8.75 5.65 11.84 
St. Columcille’s Hospital 194 9.76 5.79 13.72 
St. Michael’s Hospital 45 - - - 
Dublin Midlands  2225 8.16 7.02 9.30 
St. James's Hospital 721 9.05 6.97 11.14 
Tallaght Hospital 694 4.59 2.86 6.32 
Naas General Hospital 376 11.69 8.38 15.00 
Midland Regional Hospital Tullamore 248 8.20 5.00 11.40 
Midland Regional Hospital Portlaoise 186 9.23 5.64 12.82 
RCSI Hospitals  1995 11.44 10.06 12.82 
Beaumont Hospital 762 9.82 7.63 12.02 
Our Lady of Lourdes Hospital Drogheda 507 10.87 8.20 13.55 
Cavan General Hospital 378 13.67 10.42 16.92 
Connolly Hospital Blanchardstown 348 12.75 9.28 16.23 
UL Hospitals 994 10.62 8.79 12.46 
University Hospital Limerick 737 11.84 9.58 14.11 
Ennis Hospital 156 6.40 3.26 9.54 
Nenagh Hospital 63 - - - 
St. Johns Hospital 38 - - - 
South / South West  2645 10.96 9.81 12.10 
Cork University Hospital 977 12.59 10.55 14.62 
Kerry General Hospital 457 9.94 7.35 12.54 
University Hospital Waterford 388 9.77 6.71 12.83 
South Tipperary General Hospital 335 11.40 8.30 14.50 
Mercy University Hospital Cork 290 9.25 5.87 12.62 
Bantry General Hospital 71 - - - 
Mallow General Hospital 70 - - - 
South Infirmary/Victoria University Hospital Cork 57 - - - 
Saolta University Health Care 2329 9.20 8.08 10.31 
Galway University Hospitals 680 10.05 7.88 12.22 
Mayo General Hospital 523 11.69 9.11 14.27 
Letterkenny General Hospital 504 9.13 6.70 11.56 
Sligo General Hospital 400 5.77 3.58 7.97 
Portiuncula Hospital Ballinasloe 201 5.61 3.00 8.23 
Roscommon County Hospital 21 - - - 
Total for All Hospitals 13455 9.76 9.28 10.25 
Source: Hospital Inpatient Enquiry (HIPE) 
Note: Hospitals with small numbers of cases tend to have unstable rates and wider confidence intervals. For 
this report rates are not displayed for hospitals with less than 100 cases, although the data for these hospitals 
have been included in the calculation of the national rates.  However some hospitals with more than 100 cases 
may still have unstable rates and caution should be exercised in interpreting rates with wide confidence 
intervals.  
See Appendix 3 for detailed indicator definitions and methodology.  
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In-hospital waiting time for hip fracture surgery 
Description 
The in-hospital waiting time for hip fracture surgery indicator is defined as the proportion of 
patients aged 65 years and older with a hip fracture who have surgery within two days of 
admission.  
 
Rationale for selection of indicator  
Hip fracture, which is associated with increasing age, can lead to a significant risk of serious 
illness and sometimes death (24, 25). The standard treatment for hip fracture is surgery. It is 
known that the outcomes for patients are better if this surgery is timely i.e. that the surgery 
happens as soon as possible after admission and when the patient is ready and fit for surgery 
(26). This may mean that the patient needs to be stabilised and therefore, there can be a delay 
between admission and surgery, whether for medical stabilisation of the patient‟s co-
morbidities, or for administrative/logistical reasons. A delay in surgery can mean that as well 
as an increased length of hospital stay for the patient, there may also be an associated 
increased risk of serious illness and death.  Based on this evidence the Health Service 
Executive (HSE) has a target of 95% of emergency hip fracture surgeries to be carried out 
within 48 hours of admission.  
 
Commentary 
 The proportion of patients with a hip fracture undergoing surgery within two days 
increased slightly over the ten year period from 2004 to 2013, with 82.4% of cases in 
2013 undergoing surgery within two days compared to 78.8% in 2004 (Figure 35).  
 In 2011, the average proportion of patients with a hip fracture undergoing surgery 
within two days in Ireland was 83.2% which was higher than the OECD average of 
77.1% (Figure 36).  
 During the three year period 2011-2013 there was a variation between hospitals in the 
proportion of hip fracture cases undergoing surgery within two days with one hospital 
carrying out 65.9% of surgeries within two days while two hospitals achieved rates of 
over 95% (Table 8 and Figure 37). This variation needs to be further explored.  
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Figure 35: In-hospital waiting time for hip fracture surgery - proportion of cases with surgery within 2 days of 
admission, 2004 – 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
 
Figure 36: In-hospital waiting time for hip fracture surgery - proportion of cases with surgery within 2 days of 
admission for selected OECD countries, 2011 or latest year 
 
Source: OECD Health Statistics 
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Figure 37: In-hospital waiting time for hip fracture surgery - proportion of cases with surgery within 2 days of 
admission, 2011 – 2013 
 
Source: Hospital Inpatient Enquiry (HIPE) 
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Table 8: In-hospital waiting time for hip fracture surgery - proportion of cases with surgery within 2 days of 
admission, 2011 – 2013 
Hospital Group 
Number of Hip Fracture 
Admissions 
Percentage with Surgery 
within 2 Days 
Ireland East  1129 90.0 
St. Vincent’s University Hospital 766 95.4 
Mater Misericordiae University Hospital 363 78.5 
Dublin Midlands  1204 78.3 
Midland Regional Hospital Tullamore 500 74.0 
Tallaght Hospital 428 80.4 
St. James's Hospital 276 83.0 
RCSI Hospitals  1341 81.4 
Our Lady of Lourdes Hospital Drogheda 643 77.6 
Beaumont Hospital 412 80.3 
Connolly Hospital Blanchardstown 286 91.6 
UL Hospitals 682 85.8 
University Hospital Limerick 682 85.8 
South / South West  2307 76.6 
University Hospital Waterford 1036 84.4 
Cork University Hospital 944 65.9 
Kerry General Hospital 327 82.6 
Saolta University Health Care 1429 89.2 
Galway University Hospitals 497 92.0 
Mayo General Hospital 330 95.2 
Letterkenny General Hospital 329 85.1 
Sligo General Hospital 273 81.7 
Total for All Hospitals 8092 82.5 
 
Source: Hospital Inpatient Enquiry (HIPE) 
Note: See Appendix 3 for detailed indicator definitions and methodology.  
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Caesarean Sections  
Description 
This is defined as the rate of caesarean section deliveries per 100 live births in public 
hospitals.  
 
Rationale for selection of indicator 
The rates of caesarean sections per number of live births are commonly reported 
internationally and are also reported by the OECD. To allow for comparison with other 
OECD countries, rates of caesarean section deliveries per 100 live births in Ireland were 
calculated. These calculations do not take into account multiple births, history of caesarean 
section, or other factors which may impact on the likelihood of having a caesarean section. 
Rates of caesarean delivery as a percentage of all live births have increased in almost all 
OECD countries in recent decades with the average rate across countries going up from 20% 
in 2000 to 27% in 2011, although the growth rate in many countries has slowed down since 
2005. There are many possible reasons suggested by the OECD for these increases including 
among others reductions in the risk of caesarean delivery, increasing litigation, increases in 
first births among older women, and the rise in multiple births resulting from assisted 
reproduction (27). 
 
Commentary 
 Figure 38 shows increasing national rates of caesarean section per 100 live births 
between the years 2004 and 2013. 
 In 2011 the caesarean section rate for Ireland was 27.2 per 100 live births, which was 
above the OECD rate of 26.9 (Figure 39).  
 Table 9 and Figure 40 show variation in the rates of caesarean section per 100 live 
births in 2013 in maternity hospitals in Ireland. However, it should be noted that this 
analysis does not take into account a number of factors that are known to impact on 
caesarean section rates including age of the mother, history of caesarean section, 
multiple births, or complex presentations and pregnancies. The findings presented in 
this report are from a high level analysis. Further exploration of the identified 
variations requires these factors to be taken into account as well as data quality and 
quality of care issues.  
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Figure 38: Caesarean section rates per 100 live births, 2004 – 2013 
 
Source: National Perinatal Reporting System 
Note: Data refer to the rate of caesarean sections per 100 live births in public hospitals only and were 
provided by the Healthcare Pricing Office [December 2014].  See Appendix 3 for detailed indicator definitions 
and methodology.  
 
Figure 39: Caesarean section rates per 100 live births for selected OECD countries, 2011 or latest year 
 
Source: OECD Health Statistics 2013.  
Note: Data for Ireland refer to the rate per 100 live births in 2011 (excluding private hospitals) and were 
sourced from the National Perinatal Reporting System [Healthcare Pricing Office, December 2014]. 
1. 2010. 2. 2009 
 
24.1 
24.8 24.2 
25.3 25.7 
26.1 26.2 
27.2 
28.0 
28.8 
0
5
10
15
20
25
30
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
R
at
e
 p
e
r 
1
0
0
 L
iv
e
 B
ir
th
s 
 
14.7 
15.6 
16.2 
16.2 
16.5 
19.4 
19.8 
19.8 
19.9 
20.2 
21.2 
23.3 
24.1 
24.3 
24.9 
26.1 
26.1 
26.9 
27.2 
27.6 
28.3 
29.9 
31.1 
31.4 
32.2 
33.0 
33.4 
34.6 
34.8 
37.7 
37.7 
46.2 
49.0 
0 10 20 30 40 50 60
Iceland
Netherlands¹
Finland
Sweden
Norway²
Slovenia
Estonia
Israel
Belgium¹
France
Denmark¹
Czech Republic
United Kingdom
New Zealand
Spain
Slovak Republic¹
Canada¹
OECD32
Ireland
Luxembourg
Austria
Poland
Germany
United States¹
Australia¹
Switzerland
Hungary
Korea
Portugal
Italy
Chile¹
Turkey
Mexico
Rate per 100 Live Births 
77 | P a g e                  NHQRS Annual Report                                
 
Figure 40: Caesarean section rates per 100 live births, 2013 
 
Source: National Perinatal Reporting System 
Note: Data refer to the rate of caesarean sections per 100 live births in public hospitals only and were 
provided by the Healthcare Pricing Office [December 2014].  See Appendix 3 for detailed indicator definitions 
and methodology. 
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Table 9: Caesarean section rates per 100 live births by hospital group and hospital, 2013 
Hospital Group 
Number of Live 
Births 
Rate of Caesarean 
Sections per 100 
Live Births 
Ireland East  14,861 25.6 
National Maternity Hospital  8,715 23.1 
Midland Regional Hospital Mullingar 2,409 29.3 
Wexford County Hospital 1,962 23.1 
St. Luke's Hospital Kilkenny 1,775 35.4 
Dublin Midlands  9,912 28.4 
Coombe Women & Infants University Hospital 7,955 28.0 
Midland Regional Hospital Portlaoise 1,957 30.0 
RCSI Hospitals  14,068 30.8 
Rotunda Hospital 8,606 30.7 
Our Lady of Lourdes Hospital Drogheda 3,579 30.8 
Cavan General Hospital 1,883 31.3 
UL Hospitals 4,525 30.8 
University Maternity Hospital Limerick 4,525 30.8 
South / South West  12,936 29.3 
Cork University Maternity Hospital 8,133 30.7 
University Hospital Waterford 2,147 23.5 
Kerry General Hospital 1,471 28.5 
South Tipperary General Clonmel 1,185 31.1 
Saolta University Health Care 10,001 29.4 
Galway University Hospitals 3,044 31.6 
Portiuncula Hospital Ballinasloe 2,006 29.6 
Letterkenny General Hospital 1,761 29.9 
Mayo General Hospital 1,678 32.5 
Sligo General Hospital 1,512 21.1 
Total for All Hospitals 66,303 28.8 
Source: National Perinatal Reporting System 
Notes: Data refer to the rate of caesarean sections per 100 live births in public hospitals only and were 
provided by the Healthcare Pricing Office [December 2014].   
See Appendix 3 for detailed indicator definitions and methodology. 
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Domain 5: Treating and caring for people in a safe environment  
Health Care Associated Infections 
 
Methicillin-Resistant Staphylococcus Aureus (MRSA) infection rates 
 
Description 
Rate of MRSA bloodstream infections in acute hospital per 1,000 bed days used. Under the 
case definition for the European Antimicrobial Resistance Surveillance Network (EARS‐
Net), data are collected on the first bloodstream isolate of staphylococcus aureus per patient 
per quarter. 
 
Rationale for selection of indicator 
MRSA stands for methicillin resistant staphylococcus aureus (S. aureus). MRSA is a type of 
S. aureus that has become resistant to a number of different antibiotics and is therefore very 
difficult to treat. Most people who carry MRSA on their bodies or in their noses don‟t suffer 
any ill effects. However, MRSA sometimes causes infections and this is more likely to 
happen to people who are already unwell, particularly those who are in hospital with a serious 
illness. In a small number of people, MRSA can cause serious infections such as septicaemia 
and, in some cases, this can lead to serious illness and even death (accessed 08 December 
2014. www.hpsc.ie/A-Z). 
 
MRSA infection while in hospital can be prevented and therefore, measuring rates of MRSA 
infection is used as a quality measure in many countries. The European Antimicrobial 
Resistance Surveillance Network (EARS-Net) collects and reports on the proportion of staph 
aureus infections that are methicillin resistant for the participating countries. For some 
countries including Ireland, the trend has been positive as the proportion of staph aureus 
cases that are methicillin resistant has significantly decreased between 2010 and 2013(28). 
 
Commentary 
 Figure 41 shows national MRSA rates per 1,000 bed days used between 2004 and 2013. 
This rate has been decreasing over the last ten years with a 62% reduction.  
 Figure 42 shows Ireland and other European countries who are part of the European 
Antimicrobial Resistance Surveillance Network (EARS-Net) This international network 
80 | P a g e                  NHQRS Annual Report                                
 
publishes national figures on MRSA cases as a proportion of S. aureus,  that is the 
proportion of S. aureus that are resistant to Methicillin. This figure shows that Ireland is 
in the middle in relation to other countries for MRSA cases as a proportion of S. aureus 
cases for 2013. 
Figure 41:  MRSA rate per 1,000 bed days used, 2004 - 2013 
 
Source: Health Protection Surveillance Centre       
Note: Rates for 2004 and 2005 were calculated for acute public hospitals only     
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Figure 42: MRSA cases as a proportion of Staphylococcus Aureus cases, 2013   
 
Source: EARS-Net  
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Clostridium Difficile (C Difficile) infection rates 
 
Description 
Rate of new cases of Clostridium difficile in acute hospitals per 10,000 bed days used 
 
Rationale for selection of indicator  
Clostridium difficile (C. difficile) is a bacteria that is normally found in the large bowel. A 
small proportion (less than 1 in 20) of the healthy adult population, carry a small amount of 
C. difficile and don't experience any problem with it. However, sometimes when a person 
takes an antibiotic, some "good" bacteria die allowing the C. difficile bacteria to multiply. 
This can sometimes lead to an infection in the large bowel.  
 
Symptoms of C. difficile infection include diarrhoea, stomach cramps, fever, nausea and loss 
of appetite. Most people get mildly ill and recover fully from it but in certain circumstances, 
patients can develop serious complication including colitis (inflammation of the bowel) 
which can be life threatening. Risk factors for developing infection include older persons, 
antibiotic use, serious illness, immune-compromise (weakened immunity), recent bowel 
surgery and  long term hospitalisation or residence in other health care settings e.g., nursing 
homes (accessed 08 December 2014. www.hpsc.ie/A-Z). 
 
Control of C. difficile comprises of good antibiotic stewardship (only using antibiotics when 
required and using the right antibiotic for the infection in question) and good infection 
prevention and control such as patients, their family members and hospital staff regularly 
washing their hands, and appropriate cleaning and disinfection of equipment. C difficile rates 
in hospitals are recognised and used internationally as a good measure of the quality and 
safety of a health care service.  
 
Commentary 
Figure 43 shows new hospital acquired C difficile infection cases per 10,000 bed days used, 
between 2010 and 2013 at a national level. This rate has been decreasing over this period. 
Figure 43 also shows the number of hospitals participating in this reporting scheme is 
increasing.  
83 | P a g e                  NHQRS Annual Report                                
 
Figure 43: New hospital acquired Clostridium Difficile Infection cases per 10,000 bed days used, 2010 - 2013 
 
Source: Health Protection Surveillance Centre  
Notes:  CDI Rate refers to new HCAI Clostridium Difficile Infection cases per 10,000 bed days used 
Some hospitals may have participated for part of a year but not the whole year.  
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Conclusions 
Public reporting of patient outcomes enables patients, the public, service providers and policy 
makers to make more informed health care decisions. It empowers patients, the public and 
service providers at all levels.  Evidence from international research suggests public reporting 
of patient outcomes is an important means of improving the quality and outcome of health 
care and is also consistent with the principles of openness and transparency.  
 
This first annual report of the National Healthcare Quality Reporting System (NHQRS) 
publicly reports measures of health service performance and outcomes of care for Irish health 
services. It is the first time a report with performance and quality as its sole focus has been 
produced by the Department of Health. The purpose of the report is to use information that is 
readily available to inform questions of performance and quality which can then further 
inform the development of policy, priorities and specific service plans. It allows performance 
and outcome measures to be compared between regions and health service providers and 
allows health service performance and patient outcomes to be tracked over time. It also 
allows the comparison of Ireland‟s health service performance with that of other countries.  
 
Such comparisons, by their nature, will show variation. However they will not provide the 
explanation as to why such variation may exist. That is not their purpose. It is important that 
these measures are understood to be indicators that point to areas that require more detailed 
analysis and examination. This further examination will inform planning and delivery of 
services with the aim of improving performance. Demonstrating that there is information 
available, which establishes that variation does in fact exist, is an essential pre-requisite to the 
development of a culture of openness, responsiveness and learning that is in turn critical to 
improving care. 
 
This report highlights areas of the health services that are performing well.   
 Immunisation rates have improved in the last few years in spite of the pressures on the 
health services. 
 In-hospital mortality following admission with a heart attack decreased substantially 
between 2004 and 2013 (40% reduction).  
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 Survival rates for patients with breast and colorectal cancer are improving and at a 
rate higher than other European countries in the OECD (27).  
 National hospitalisation rates for asthma and diabetes are decreasing and are below 
the OECD average.  
 The national rates of MRSA and C. Difficile infections have improved in recent years.  
 The proportion of patients undergoing hip fracture surgery within the recommended 
time of two days in Ireland is higher than the OECD average.  
 
The report also importantly highlights areas in the health services where there is room for 
improvement.  
 Cancer survival for cervical cancer is not as yet improving.  
 There has been a reduction in the uptake for breast cancer screening in recent years.  
 Older women have lower uptake rates for cervical cancer screening.  
 Rates of hospitalisation for asthma, chronic obstructive pulmonary disease (COPD) 
and diabetes vary substantially across the country. 
 In-hospital mortality for patients admitted with a heart attack or stroke varies between 
individual hospitals with a small number of hospitals having rates that are statistically 
significantly higher than the national average.  
 The proportion of cases undergoing hip fracture surgery within the recommended two 
days of admission varies between individual hospitals. 
 The rate of caesarean sections varies between individual hospitals.  
 
The performance and quality of a service cannot be measured by one indicator alone. What is 
required is an analysis of a range of indicators that reflect different aspects of the service. It is 
possible that some pieces of information highlighted during the development of this report 
may require a more immediate assessment of quality in a specific service. Any information, 
therefore, which showed a significant variation in respect of services was fed back to the HSE 
to enable an appropriate examination and follow-up to take place.  
 
This report is published against a backdrop of information that is already available in the 
public domain. For example, immunisation uptake rates are reported on a quarterly basis by 
the HSE-Health Protection Surveillance Centre (HPSC); the National Cancer Registry of 
Ireland regularly publishes cancer survival rates and the National Screening Service publicly 
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publishes information on specific cancer screening programmes e.g. Breastcheck annual 
reports. 
 
The HSE, sponsored by its Quality Improvement Division, is developing quality profiles for 
all of its services which will include key quality indicators such as patient experience. In the 
specific area of hospital mortality a Comparative Audit of Hospital Mortality (CAHM) has 
been developed. This tool will be used by all acute hospitals to audit in-hospital deaths and 
will also assist hospitals in examining findings from the audits and from other reports such as 
the NHQRS annual report.The HSE has committed to reporting these in-hospital mortality 
rates by the end of 2015.  
 
The information in this report will inform strategic decisions being made about the health 
services. The Minister for Health has set out his priorities for 2015. These include a focus on 
improved patient outcomes including reduced waiting times for inpatient and outpatient 
appointments and improving integrated care and the management of chronic diseases. The 
information in this report is aligned with and supports decision making for these priority 
areas.   
 
The information on hospitalisation rates for chronic disease such as asthma, COPD and 
diabetes, particularly the variation across the country, can inform the development and 
implementation of models of integrated care and the development of GP contracts. Also 
information in this report relating to cancer can inform decisions about the further 
development of cancer services including screening services and also feed into the new 
cancer strategy that is to be developed in the next year.  
 
It is important to note that commitments contained in the HSE National Service Plan 2015 to 
report measures and indicators (at a more detailed level) are aligned with the information 
reported in the NHQRS.  
 
The NHQRS reports specific performances measures and patient outcomes in five key 
domains. Each of these domains is important and it is intended that indicators will be reported 
for all of them. As this is the first annual report the indicators selected reflect what was 
available and feasible, while also ensuring their relevance and value. However, the range of 
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indicators reported through the NHQRS will evolve so that in future reports they will reflect 
the care provided by all parts of the health services.   
 
At present, there is no indicator that can be reported for Domain Four: Supporting people to 
have positive experiences of health care. This is because currently there are no standardised 
comparable surveys applied across the health sector. This is recognised as a significant gap 
and will be addressed by the HSE, the Department of Health and HIQA working together to 
address this with the intention of reporting relevant indicators in the second annual report of 
the NHQRS.     
 
This annual report is only the first step in building a national public reporting system that 
focuses on outcomes that are important to patients, and that are a reflection of the breadth of 
health services provided in Ireland.  Nonetheless, it is an important first step. It enables a 
more informed public discourse about the quality of care and the performance of Irish health 
services. Everyone, the public, patient, and providers can participate in this public discourse, 
which will then have the potential to lead to real improvements in the quality of health 
services in Ireland.   
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Appendix 1: Governance Committee members 
 
Deirdre Mulholland (chair) Deputy Chief Medical Officer, Department of Health 
Tony Holohan, Chief Medical Officer, Department of Health 
Gráinne Cosgrove, Information Unit, Department of Health  
Alan Cahill, Information Unit, Department of Health  
Jennifer Martin, Quality Improvement Division*, Health Service Executive (up to January 
2015) 
Michael Carton, Quality Improvement Division*, Health Service Executive (joined January 
2015) 
Pat Kirwan, State Claims Agency 
Brigid Doherty, Patient Focus 
Helen Byrne, Acute Hospitals Division, Health Service Executive 
Rosemary Smith, Mental Health Commission 
Jane Grimson, Health Information and Quality Authority (retired September 2014) 
Rachel Flynn, Information Directorate, Health Information and Quality Authority (replacing 
Jane Grimson September 2014) 
Gerard O‟Callaghan, Voluntary Hospitals CEO Group  
Orlaith O‟Reilly, Health and Wellbeing Division, Health Service Executive  
Sinead Quill, Acute Hospitals Unit, Department of Health  
Paula Monks, Department of Health 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*  The Quality Improvement Division, HSE  was known as the Patient Safety and Quality 
Directorate, HSE prior to January 2015. 
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Appendix 2: Hospital Groups 
 
No. Composition  
i 
RCSI Hospitals:  Beaumont Hospital; Our Lady of Lourdes Hospital, Drogheda;  
Connolly Hospital; Cavan General Hospital; Rotunda Hospital; Louth County 
Hospital; Monaghan Hospital. (Academic Partner: RCSI). 
ii 
Dublin Midlands: St James's Hospital; The Adelaide & Meath Hospital, Dublin, 
including the National Children's Hospital; Midlands Regional Hospital, Tullamore; 
Naas General Hospital; Midlands Regional Hospital Portlaoise; the Coombe Women 
& Infant University Hospital. (Academic Partner: TCD). 
iii 
Ireland East:  Mater Misericordiae University Hospital; St Vincent's University 
Hospital; Midland Regional Hospital Mullingar; St Luke's General Hospital, 
Kilkenny; Wexford General Hospital; National Maternity Hospital; Our Lady's 
Hospital, Navan; St Columcille's Hospital; St Michael's Hospital, Dun Laoghaire; 
Cappagh National Orthopaedic Hospital; Royal Victoria Eye and Ear Hospital. 
(Academic Partner: UCD). 
iv 
South/South West: Cork University Hospital/CUMH; University Hospital 
Waterford; Kerry General Hospital; Mercy University Hospital; South Tipperary 
General Hospital; South Infirmary Victoria University Hospital; Bantry General 
Hospital; Mallow General Hospital, Lourdes Orthopaedic Hospital, Kilcreene. 
(Academic Partner: UCC). 
v 
Saolta University Health Care: University Hospital Galway; Merlin Park 
University Hospital; Sligo Regional Hospital; Letterkenny General Hospital; Mayo 
General Hospital; Portiuncula Hospital Ballinasloe; Roscommon Hospital.  
(Academic Partner: NUIG). 
vi 
UL Hospitals: University Hospital Limerick; Ennis Hospital; Nenagh Hospital; St 
John's Hospital Limerick; University Maternity Hospital Limerick; Croom 
Orthopaedic Hospital.  (Academic Partner: UL). 
vii 
Children’s Hospital Group: The acute paediatric services in Dublin; Our Lady's 
Children's Hospital - Crumlin, Children's University Hospital Temple Street, and the 
paediatric service in AMNCH – Tallaght. (Academic Partner: All Universities) 
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Appendix 3: Indicator Definitions and Methodology 
 
Indicator Immunisation rates for MMR at 24 months 
Definition 
% of children 24 months of age who have received the MMR (measles, mumps and 
rubella) vaccine 
Years 
Covered 
  
National trend: 2004 – 2013 
Local Health Office comparison: 2013 
 
Classification N/A 
Methodology Numerator: 
Number of children who have received the 1
st
 dose of MMR vaccination by their second 
birthday. 
Denominator: 
Number of children who have reached their second birthday. 
 
 Notes  The 2005 national MMR figure is incomplete, as Quarter 4 2005 MMR data were not 
available for the HSE-Eastern area due to technical problems with extraction of MMR data 
from the HSE-Eastern Area database. 
The 2006 national MMR figure includes the Quarter 1 2006 HSE-Eastern data, which is an 
estimate only.  This is due to technical problems with extraction of MMR data from the 
HSE-Eastern Area database. 
Data for Q3 2008 were not available for 2 regions. 
The data for 2009 and 2010 are incomplete as data for some regions were incomplete. 
  
Data 
Source(s) 
  
Health Protection Surveillance Centre 
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Indicator Immunisation rates for Meningitis C at 24 months 
Definition % of children 24 months of age who have received third dose of the Meningitis C vaccine 
Years 
Covered 
  
National trend: 2004 – 2013 
Local Health Office comparison: 2013 
 
Classification N/A 
Methodology Numerator: 
Number of children who have received 3 doses of the Meningitis C vaccination by their 
second birthday. 
Denominator: 
Number of children who have reached their second birthday. 
 
 Notes Data for Q3 2008 were not available for 2 regions. 
The data for 2009 and 2010 are incomplete as data for some regions were incomplete. 
  
Data 
Source(s) 
  
 Health Protection Surveillance Centre 
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Indicator Immunisation against influenza for persons aged 65 years and over with medical card 
Definition 
% of people aged 65 years and over with a medical card or GP Visit Card who have been 
vaccinated against influenza. 
Years 
Covered 
  
National trend: 2003 – 2013 
 
Classification N/A 
Methodology Numerator: 
Number of medical card and GP Visit Card holders aged 65 years and over who have 
received the influenza vaccine from a GP or (from 2012/2013) from a pharmacist. 
Denominator: 
Number of medical card and GP Visit Card holders aged 65 years and over. 
 
 Notes Data for 2013 are provisional. 
Influenza vaccine data relate to paid claims for influenza vaccine reimbursement for medical 
card holders and GP Visit Card holders aged 65 years old and over attending GP clinics and 
pharmacies for influenza vaccination.  Data from pharmacies were only available from the 
2012/2013 influenza season when administration of influenza vaccine by pharmacists 
commenced. 
 
Data reported for 2013 (i.e. 2013-2014 season) are provisional. 
 
Data for 2008 refer to the 2008/2009 season (September-August), 2009 refer to the 
2009/2010 season etc.      
 
  
Data 
Source(s) 
  
 Health Protection Surveillance Centre 
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Indicator Screening rate for breast cancer 
Definition Percentage uptake of breast screening by eligible women in the population 
Years 
Covered 
  
National: 2004-2013 
Classification N/A 
Methodology Numerator: the number of eligible women in the population who were invited in the 
reporting period and have had a satisfactory screening test 
Denominator: the number of eligible  women invited in the reporting period 
 Notes 
The eligible population refers to the known target population (women of screening age that 
are known to the programme) less those women excluded or suspended by the programme 
based on certain eligibility criteria. 
       
Excluded – women in follow up care for breast cancer, not contactable by An Post, women 
who have a physical/mental incapacity (while BreastCheck attempts to screen all eligible 
women, certain forms of physical or mental incapacity may preclude screening), terminal 
illness or other.  
Suspended – women on extended vacation or working abroad, women who had a 
mammogram within the last year, women who opt to wait until the next round, women who 
wished to defer appointment, women unwilling to reschedule or other. 
  
Data 
Source(s) 
  
  National Screening Service 
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Indicator Screening rate for cervical cancer 
Definition 
The proportion of the eligible population in Ireland who had a satisfactory smear test within a 
five year time period. 
Years 
Covered 
  
National: (Rolling) 5-year period covering 01/09/2008-31/08/2013 
Classification N/A 
Methodology Numerator: the number of women in the eligible population who have had a satisfactory 
smear test in the 5-year reporting period 
Denominator: the number of eligible women in the population at the mid-point of the 5-year 
reporting period 
 Notes This is a rolling parameter which is updated each year to incorporate the previous 5-year 
period 
  
Data 
Source(s) 
  
  National Screening Service 
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Indicator COPD Hospitalisation Rate 
Definition The age-sex standardised rate of hospitalisations of people aged 15 years and older with a 
principal diagnosis of chronic obstructive pulmonary disease (COPD) per 100,000 
population.   
Years 
Covered 
  
National trend: 2005 – 2013 
OECD comparison: 2011 
County of residence: 2011 – 2013 (aggregated)  
Classification ICD-10-AM J41, J42, J43, J44, J47 or J40 with a secondary diagnosis of J41, J43, J44 or 
J47   
Methodology Numerator: 
Number of hospital discharges with a principal diagnosis of COPD in a specified year, ages 
15 and over. 
Denominator: 
Population aged 15 years and older. 
Exclusions: 
i. Cases transferred in from another acute hospital 
ii. Cases in Major Diagnostic Categories 14 (Pregnancy, Childbirth & Puerperium) or 
15 (Newborns & Other Neonates) 
iii. Cases that are discharged on the day of admission 
Age-sex standardisation:  
Data have been age and sex standardised based on the methodology developed and used by 
the OECD Health Care Quality Indicators (HCQI) data collection.  
Age-sex standardised rates facilitate comparison of rates between populations of different 
age composition (for example hospitals or countries) and also of rates over time.  The age-
sex standardised rate is the number of cases per 100,000 population that would occur if the 
county or year had the same age structure as the OECD Standard Population and the local 
age-sex specific rates applied.  
Age-sex standardised rates and associated confidence limits are calculated as follows: 
i. The number of cases in the numerator and the population (i.e. the denominator) are 
calculated by males and females for each 5 year age-group from 15-19 to 85+ years. 
ii. Age & sex specific rates are calculated for males and females for each age-group. 
iii. The age & sex specific rates are multiplied by the number of cases in the OECD 
standard population (based on the total OECD population in 2010) 
iv. The age-sex standardised hospitalisation rate (ASR) is then calculated as the sum of 
the age & sex specific rates multiplied by the standard population, and divided by 
the total number of cases in the standard population. 
v. Upper and lower confidence intervals are presented at the 95% confidence level, and 
are calculated by  
                             ASR ± 1.96 * Standard Error of ASR 
where the standard error is determined from a binomial distribution. 
Note that the age-sex standardised hospitalisation rates at county of residence level for 2011 
to 2013 refer to the average annual rate over the three year period. 
 Notes Data are based on discharges from publicly funded acute hospitals; private hospitals are not 
included. A small number of non-acute hospitals that are not included in the seven hospital 
groups participate in HIPE for historical reasons; these hospitals have been removed from 
this analysis.  
95% confidence intervals have been produced and these should be considered when 
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interpreting the age-standardised rates.  Where the lower limit of the 95% confidence interval 
is above the upper 95% confidence limit of the national rate, it can be said that the rate is 
statistically significantly higher than the national rate at the 95% confidence level. Similarly, 
where the upper limit of the 95% confidence interval is below the lower 95% confidence 
limit of the national rate, it can be said that the rate is statistically significantly lower than the 
national rate at the 95% confidence level.  Note that areas with small numbers of cases tend 
to have unstable rates and wider confidence intervals. Caution should be exercised in 
interpreting rates with wide confidence intervals.  
Since 2005 HIPE data have been coded using the Australian Modification of ICD-10, IC D-
10-AM. Prior to 2005 the ICD-9-CM classification was used. The differences between these 
classifications mean that for certain diagnoses comparison of data from 2004 and earlier 
years with data from 2005 onwards is difficult. For this reason data from 2004 and earlier 
years is not included in the calculation of this indicator.  
 Data 
Source(s) 
  
 Hospital In-Patient Enquiry (HIPE) 
The Healthcare Pricing Office (HPO) manages the HIPE system. For more information on 
HIPE see http://www.hpo.ie. 
The data presented for this indicator are based on analysis of HIPE data carried out by the 
Department of Health using the definitions and methodology developed by the OECD Health 
Care Quality Indicators (HCQI) project.  
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Indicator Asthma Hospitalisation Rate 
Definition The age-sex standardised rate of hospitalisations of people aged 15 years and older with a 
principal diagnosis of asthma per 100,000 population.   
Years 
Covered 
  
National trend: 2005 – 2013 
OECD comparison: 2011 
County of residence: 2011 – 2013 (aggregated)  
Classification ICD-10-AM J45 or J46 
Methodology Numerator: 
Number of hospital discharges with a principal diagnosis of asthma in a specified year, ages 
15 and over. 
Denominator: 
Population aged 15 years and older. 
Exclusions: 
iv. Cases transferred in from another acute hospital 
v. Cases in Major Diagnostic Categories 14 (Pregnancy, Childbirth & Puerperium) or 
15 (Newborns & Other Neonates) 
vi. Cases with any diagnosis code of cystic fibrosis and anomalies of the respiratory 
system  [ICD-10-AM E84, P27, Q25.4, Q31.1 - Q34.9, Q39.0 - Q39.4, Q39.8, 
Q89.3] 
vii. Cases that are discharged on the day of admission 
Age-sex standardisation:  
Data have been age and sex standardised based on the methodology developed and used by 
the OECD Health Care Quality Indicators (HCQI) data collection.  
Age-sex standardised rates facilitate comparison of rates between populations of different 
age composition (for example hospitals or countries) and also of rates over time.  The age-
sex standardised rate is the number of cases per 100,000 population that would occur if the 
county or year had the same age structure as the OECD Standard Population and the local 
age-sex specific rates applied.  
Age-sex standardised rates and associated confidence limits are calculated as follows: 
i. The number of cases in the numerator and the population (i.e. the denominator) are 
calculated by males and females for each 5 year age-group from 15-19 to 85+ years. 
ii. Age & sex specific rates are calculated for males and females for each age-group. 
iii. The age & sex specific rates are multiplied by the number of cases in the OECD 
standard population (based on the total OECD population in 2010) 
iv. The age-sex standardised hospitalisation rate (ASR) is then calculated as the sum of 
the age & sex specific rates multiplied by the standard population, and divided by 
the total number of cases in the standard population. 
v. Upper and lower confidence intervals are presented at the 95% confidence level, and 
are calculated by  
                             ASR ± 1.96 * Standard Error of ASR 
where the standard error is determined from a binomial distribution. 
Note that the age-sex standardised hospitalisation rates at county of residence level for 2011 
to 2013 refer to the average annual rate over the three year period. 
 Notes Data are based on discharges from publicly funded acute hospitals; private hospitals are not 
included. A small number of non-acute hospitals that are not included in the seven hospital 
groups participate in HIPE for historical reasons; these hospitals have been removed from 
this analysis.  
95% confidence intervals have been produced and these should be considered when 
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interpreting the age-standardised rates.  Where the lower limit of the 95% confidence interval 
is above the upper 95% confidence limit of the national rate, it can be said that the rate is 
statistically significantly higher than the national rate at the 95% confidence level. Similarly, 
where the upper limit of the 95% confidence interval is below the lower 95% confidence 
limit of the national rate, it can be said that the rate is statistically significantly lower than the 
national rate at the 95% confidence level.  Note that areas with small numbers of cases tend 
to have unstable rates and wider confidence intervals. Caution should be exercised in 
interpreting rates with wide confidence intervals.  
Since 2005 HIPE data have been coded using the Australian Modification of ICD-10, IC D-
10-AM. Prior to 2005 the ICD-9-CM classification was used. The differences between these 
classifications mean that for certain diagnoses comparison of data from 2004 and earlier 
years with data from 2005 onwards is difficult. For this reason data from 2004 and earlier 
years is not included in the calculation of this indicator. 
  
Data 
Source(s) 
  
  
Hospital In-Patient Enquiry (HIPE) 
The Healthcare Pricing Office (HPO) manages the HIPE system. For more information on 
HIPE see http://www.hpo.ie. 
The data presented for this indicator are based on analysis of HIPE data carried out by the 
Department of Health using the definitions and methodology developed by the OECD Health 
Care Quality Indicators (HCQI) project.  
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Indicator Diabetes Hospitalisation Rate 
Definition The age-sex standardised rate of hospitalisations of people aged 15 years and older with a 
principal diagnosis of diabetes per 100,000 population.   
Years 
Covered 
  
National trend: 2005 – 2013 
OECD comparison: 2011 
County of residence: 2011 – 2013 (aggregated)  
Classification ICD-10-AM E10 –E14 
Methodology Numerator: 
Number of hospital discharges with a principal diagnosis of diabetes in a specified year, ages 
15 and over. 
Denominator: 
Population aged 15 years and older. 
Exclusions: 
viii. Cases transferred in from another acute hospital 
ix. Cases in Major Diagnostic Categories 14 (Pregnancy, Childbirth & Puerperium) or 
15 (Newborns & Other Neonates) 
x. Cases that are discharged on the day of admission 
Age-sex standardisation:  
Data have been age and sex standardised based on the methodology developed and used by 
the OECD Health Care Quality Indicators (HCQI) data collection.  
Age-sex standardised rates facilitate comparison of rates between populations of different 
age composition (for example hospitals or countries) and also of rates over time.  The age-
sex standardised rate is the number of cases per 100,000 population that would occur if the 
county or year had the same age structure as the OECD Standard Population and the local 
age-sex specific rates applied.  
Age-sex standardised rates and associated confidence limits are calculated as follows: 
i. The number of cases in the numerator and the population (i.e. the denominator) are 
calculated by males and females for each 5 year age-group from 15-19 to 85+ years. 
ii. Age & sex specific rates are calculated for males and females for each age-group. 
iii. The age & sex specific rates are multiplied by the number of cases in the OECD 
standard population (based on the total OECD population in 2010) 
iv. The age-sex standardised hospitalisation rate (ASR) is then calculated as the sum of 
the age & sex specific rates multiplied by the standard population, and divided by 
the total number of cases in the standard population. 
v. Upper and lower confidence intervals are presented at the 95% confidence level, and 
are calculated by  
                             ASR ± 1.96 * Standard Error of ASR 
where the standard error is determined from a binomial distribution. 
Note that the age-sex standardised hospitalisation rates at county of residence level for 2011 
to 2013 refer to the average annual rate over the three year period. 
 Notes Data are based on discharges from publicly funded acute hospitals; private hospitals are not 
included. A small number of non-acute hospitals that are not included in the seven hospital 
groups participate in HIPE for historical reasons; these hospitals have been removed from 
this analysis.  
95% confidence intervals have been produced and these should be considered when 
interpreting the age-standardised rates.  Where the lower limit of the 95% confidence interval 
is above the upper 95% confidence limit of the national rate, it can be said that the rate is 
statistically significantly higher than the national rate at the 95% confidence level. Similarly, 
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where the upper limit of the 95% confidence interval is below the lower 95% confidence 
limit of the national rate, it can be said that the rate is statistically significantly lower than the 
national rate at the 95% confidence level.  Note that areas with small numbers of cases tend 
to have unstable rates and wider confidence intervals. Caution should be exercised in 
interpreting rates with wide confidence intervals.  
Since 2005 HIPE data have been coded using the Australian Modification of ICD-10, IC D-
10-AM. Prior to 2005 the ICD-9-CM classification was used. The differences between these 
classifications mean that for certain diagnoses comparison of data from 2004 and earlier 
years with data from 2005 onwards is difficult. For this reason data from 2004 and earlier 
years is not included in the calculation of this indicator. 
  
Data 
Source(s) 
  
  
Hospital In-Patient Enquiry (HIPE) 
The Healthcare Pricing Office (HPO) manages the HIPE system. For more information on 
HIPE see http://www.hpo.ie. 
The data presented for this indicator are based on analysis of HIPE data carried out by the 
Department of Health using the definitions and methodology developed by the OECD Health 
Care Quality Indicators (HCQI) project.  
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Indicator Breast cancer survival rates 
Definition 
Age-standardised estimates of cumulative 5-year relative survival for Irish female breast 
cancer patients for the period 2005-2010 
Years 
Covered 
  
National and HSE Region: cohort 2005-2010 
OECD: cohorts 2001-2006 and 2006-2011 (or nearest period) 
Classification ICD10 C50, ICD9 174 
Methodology Age-standardized Period estimates of Ederer II relative survival for the follow-up period 
2005-2010.  
Five-year observed survival for women aged 15-99 diagnosed with breast cancer (first 
primary cancer at the specified site) divided by the expected survival of a comparable group 
from the general population (expressed in percentage). 
Survival estimates are standardized to the International Cancer Survival Standard (ICSS) 
populations by Corazziari I., Quinn M. & Capocaccia R. 2004. Standard cancer patient 
population for age standardising survival ratios. Eur J Cancer 40: 2307-2316. 
 Notes Exclusions: 
Patients aged <15 or >99 at diagnosis; death-certificate-only (DCO) and autopsy-only cases; 
second or subsequent malignancies in the same patient (or the less serious of two or more 
synchronously-diagnosed malignancies); in situ carcinomas, benign tumours and tumours of 
uncertain behaviour. 
Cancer registration is a dynamic process and information is continually updated on the NCRI 
database.  
As a result, the figures given here may not correspond exactly to those in previous reports or 
to those previously shown on the NCRI website. 
  
Data 
Source(s) 
  
  
 National Cancer Registry of Ireland. 
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Indicator Cervical cancer survival rates 
Definition 
Age-standardised estimates of cumulative 5-year relative survival for Irish cervical cancer 
patients for the period 2005-2010 
Years 
Covered 
  
National and HSE Region: cohort 2005-2010 
OECD: cohorts 2001-2006 and 2006-2011 (or nearest period) 
Classification ICD10 C53, ICD9 180 
Methodology Age-standardized Period estimates of Ederer II relative survival for the follow-up period 
2005-2010.  
Five-year observed survival for women aged 15-99 diagnosed with cervical cancer (first 
primary cancer at the specified site) divided by the expected survival of a comparable group 
from the general population (expressed in percentage). 
Survival estimates are standardized to the International Cancer Survival Standard (ICSS) 
populations by Corazziari I., Quinn M. & Capocaccia R. 2004. Standard cancer patient 
population for age standardising survival ratios. Eur J Cancer 40: 2307-2316. 
 Notes Exclusions: 
Patients aged <15 or >99 at diagnosis; death-certificate-only (DCO) and autopsy-only cases; 
second or subsequent malignancies in the same patient (or the less serious of two or more 
synchronously-diagnosed malignancies); in situ carcinomas, benign tumours and tumours of 
uncertain behaviour. 
Cancer registration is a dynamic process and information is continually updated on the NCRI 
database.  
As a result, the figures given here may not correspond exactly to those in previous reports or 
to those previously shown on the NCRI website. 
  
Data 
Source(s) 
  
  
 National Cancer Registry of Ireland. 
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Indicator Colorectal cancer survival rates 
Definition 
Age-standardised estimates of cumulative 5-year relative survival for Irish colorectal cancer 
patients for the period 2005-2010 
Years 
Covered 
  
National and HSE Region: cohort 2005-2010 
OECD: cohorts 2001-2006 and 2006-2011 (or nearest period) 
Classification ICD10 C18-21, ICD9 153-154 
Methodology Age-standardized Period estimates of Ederer II relative survival for the follow-up period 
2005-2010.  
Five-year observed survival for the total population aged 15-99 diagnosed with colorectal 
cancer (first primary cancer at the specified site) divided by the expected survival of a 
comparable group from the general population (expressed in percentage). 
Survival estimates are standardized to the International Cancer Survival Standard (ICSS) 
populations by Corazziari I., Quinn M. & Capocaccia R. 2004. Standard cancer patient 
population for age standardising survival ratios. Eur J Cancer 40: 2307-2316. 
 Notes Exclusions: 
Patients aged <15 or >99 at diagnosis; death-certificate-only (DCO) and autopsy-only cases; 
second or subsequent malignancies in the same patient (or the less serious of two or more 
synchronously-diagnosed malignancies); in situ carcinomas, benign tumours and tumours of 
uncertain behaviour. 
Cancer registration is a dynamic process and information is continually updated on the NCRI 
database.  
As a result, the figures given here may not correspond exactly to those in previous reports or 
to those previously shown on the NCRI website. 
  
Data 
Source(s) 
  
  
 National Cancer Registry of Ireland. 
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Indicator In-hospital Mortality following Acute Myocardial Infarction 
Definition The age-sex standardised mortality rate within 30 days of admission with a principal 
diagnosis of Acute Myocardial Infarction (AMI), ages 45 and over.  
Years 
Covered  
National trend: 2004 – 2013 
OECD comparison: 2011 
Hospital & hospital group level: 2011 – 2013 (aggregated)  
Classification ICD-9-CM 410 & ICD-10-AM I21 or I22.   
Methodology Numerator: 
Number of deaths in hospital that occurred within 30 days of hospital admission with a 
principal diagnosis of acute myocardial infarction in a specified year, ages 45 and over. 
Denominator: 
Number of hospitalisations of patients aged 45 and over with a principal diagnosis of acute 
myocardial infarction in the specified year. 
Age-sex standardisation:  
Data have been age and sex standardised based on the methodology developed and used by 
the OECD Health Care Quality Indicators (HCQI) data collection.  
Age-sex standardised rates facilitate comparison of rates between populations of different 
age composition (for example hospitals or countries) and also of rates over time.  The age-
sex standardised death rate (ASDR) is the number of deaths per 100 cases that would occur if 
the hospital, country or year had the same age structure as the OECD Standard Population 
and the local age-sex specific rates applied.  
Age-sex standardised deaths rates (ASDRs) and associated confidence limits are calculated 
as follows: 
i. The number of deaths and cases are calculated by males and females for each 5 year 
age-group from 45-49 to 85+ years. 
ii. Age & sex specific death rates are calculated for males and females for each age-
group. 
iii. The age & sex specific death rates are multiplied by the number of cases in the 
OECD standard population (based on the total number of AMI hospitalisations in 
the OECD) 
iv. The age-sex standardised death rate (ASDR) is then calculated as the sum of the age 
& sex specific rates multiplied by the standard population, and divided by the total 
number of cases in the standard population. 
v. Upper and lower confidence intervals are presented at the 95% confidence level, and 
are calculated by  
                             ASDR ± 1.96 * Standard Error of ASDR 
where the standard error is determined from a binomial distribution. 
 Notes Data are based on discharges from publicly funded acute hospitals; private hospitals are not 
included. Data have been analysed at hospital and hospital group level (see Appendix for 
hospital groups). A small number of non-acute hospitals that are not included in the seven 
hospital groups participate in HIPE for historical reasons; these hospitals have been removed 
from this analysis.  
95% confidence intervals have been produced and these should be considered when 
interpreting the age-standardised death rates.  Where the lower limit of the 95% confidence 
interval is above the upper 95% confidence limit of the national rate, it can be said that the 
rate is statistically significantly higher than the national rate at the 95% confidence level. 
Similarly, where the upper limit of the 95% confidence interval is below the lower 95% 
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confidence limit of the national rate, it can be said that the rate is statistically significantly 
lower than the national rate at the 95% confidence level.  Note that hospitals with small 
numbers of cases tend to have unstable rates and wider confidence intervals. For this report 
rates are not displayed for hospitals with less than 100 denominator cases, although the data 
for these hospitals have been included in the calculation of the national rates.  However some 
hospitals with more than 100 cases may still have unstable rates and caution should be 
exercised in interpreting rates with wide confidence intervals.  
It is important to note that transfer patterns between hospitals have the potential to influence 
the in-hospital mortality rates.  For some conditions there can be significant volumes of 
patients being transferred out of hospitals and being transferred into other hospitals. The 
indicators presented in this report are high-level indicators and therefore do not take transfer 
patterns into account. A more refined analysis of transfer patterns would be required to assess 
the full effect of transfers on the in-hospital mortality rates.  
  
Data 
Source(s) 
  
  
Hospital In-Patient Enquiry (HIPE) 
The Healthcare Pricing Office (HPO) manages the HIPE system. For more information on 
HIPE see http://www.hpo.ie. 
The data presented for this indicator are based on analysis of HIPE data carried out by the 
Department of Health using the definitions and methodology developed by the OECD Health 
Care Quality Indicators (HCQI) project.  
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Indicator In-hospital Mortality following Haemorrhagic Stroke 
Definition The age-sex standardised mortality rate within 30 days of admission with a principal 
diagnosis of haemorrhagic stroke, ages 45 and over.  
Years 
Covered 
National trend: 2004 – 2013 
OECD comparison: 2011 
Hospital & hospital group level: 2011 – 2013 (aggregated)  
Classification ICD-9-CM 430 – 432 & ICD-10-AM I60 - I62.   
Methodology Numerator: 
Number of deaths in hospital that occurred within 30 days of hospital admission with a 
principal diagnosis of haemorrhagic stroke in a specified year, ages 45 and over. 
Denominator: 
Number of hospitalisations of patients aged 45 and over with a principal diagnosis of 
haemorrhagic stroke in the specified year. 
Age-sex standardisation:  
Data have been age and sex standardised based on the methodology developed and used by 
the OECD Health Care Quality Indicators (HCQI) data collection.  
Age-sex standardised rates facilitate comparison of rates between populations of different 
age composition (for example hospitals or countries) and also of rates over time.  The age-
sex standardised death rate (ASDR) is the number of deaths per 100 cases that would occur if 
the hospital, country or year had the same age structure as the OECD Standard Population 
and the local age-sex specific rates applied.  
Age-sex standardised deaths rates (ASDRs) and associated confidence limits are calculated 
as follows: 
i. The number of deaths and cases are calculated by males and females for each 5 year 
age-group from 45-49 to 85+ years. 
ii. Age & sex specific death rates are calculated for males and females for each age-
group. 
iii. The age & sex specific death rates are multiplied by the number of cases in the 
OECD standard population (based on the total number of haemorrhagic stroke 
hospitalisations in the OECD) 
iv. The age-sex standardised death rate (ASDR) is then calculated as the sum of the age 
& sex specific rates multiplied by the standard population, and divided by the total 
number of cases in the standard population. 
v. Upper and lower confidence intervals are presented at the 95% confidence level, and 
are calculated by  
                             ASDR ± 1.96 * Standard Error of ASDR 
where the standard error is determined from a binomial distribution. 
 Notes Data are based on discharges from publicly funded acute hospitals; private hospitals are not 
included. Data have been analysed at hospital and hospital group level (see Appendix for 
hospital groups). A small number of non-acute hospitals that are not included in the seven 
hospital groups participate in HIPE for historical reasons; these hospitals have been removed 
from this analysis.  
95% confidence intervals have been produced and these should be considered when 
interpreting the age-standardised death rates.  Where the lower limit of the 95% confidence 
interval is above the upper 95% confidence limit of the national rate, it can be said that the 
rate is statistically significantly higher than the national rate at the 95% confidence level. 
Similarly, where the upper limit of the 95% confidence interval is below the lower 95% 
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confidence limit of the national rate, it can be said that the rate is statistically significantly 
lower than the national rate at the 95% confidence level.  Note that hospitals with small 
numbers of cases tend to have unstable rates and wider confidence intervals. For this report 
rates are not displayed for hospitals with less than 100 denominator cases, although the data 
for these hospitals have been included in the calculation of the national rates.  However some 
hospitals with more than 100 cases may still have unstable rates and caution should be 
exercised in interpreting rates with wide confidence intervals.  
It is important to note that transfer patterns between hospitals have the potential to influence 
the in-hospital mortality rates.  For some conditions there can be significant volumes of 
patients being transferred out of hospitals and being transferred into other hospitals. The 
indicators presented in this report are high-level indicators and therefore do not take transfer 
patterns into account. A more refined analysis of transfer patterns would be required to assess 
the full effect of transfers on the in-hospital mortality rates.  
  
Data 
Source(s) 
  
  
Hospital In-Patient Enquiry (HIPE) 
The Healthcare Pricing Office (HPO) manages the HIPE system. For more information on 
HIPE see http://www.hpo.ie. 
The data presented for this indicator are based on analysis of HIPE data carried out by the 
Department of Health using the definitions and methodology developed by the OECD Health 
Care Quality Indicators (HCQI) project.  
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Indicator In-hospital Mortality following Ischaemic Stroke 
Definition The age-sex standardised mortality rate within 30 days of admission with a principal 
diagnosis of ischaemic stroke, ages 45 and over.  
Years 
Covered 
  
National trend: 2004 – 2013 
OECD comparison: 2011 
Hospital & hospital group level: 2011 – 2013 (aggregated)  
Classification ICD-9-CM 433, 434 or 436 & ICD-10-AM I63 - I64.   
Methodology Numerator: 
Number of deaths in hospital that occurred within 30 days of hospital admission with a 
principal diagnosis of ischaemic stroke in a specified year, ages 45 and over. 
Denominator: 
Number of hospitalisations of patients aged 45 and over with a principal diagnosis of 
ischaemic stroke in the specified year. 
Age-sex standardisation:  
Data have been age and sex standardised based on the methodology developed and used by 
the OECD Health Care Quality Indicators (HCQI) data collection.  
Age-sex standardised rates facilitate comparison of rates between populations of different 
age composition (for example hospitals or countries) and also of rates over time.  The age-
sex standardised death rate (ASDR) is the number of deaths per 100 cases that would occur if 
the hospital, country or year had the same age structure as the OECD Standard Population 
and the local age-sex specific rates applied.  
Age-sex standardised deaths rates (ASDRs) and associated confidence limits are calculated 
as follows: 
i. The number of deaths and cases are calculated by males and females for each 5 year 
age-group from 45-49 to 85+ years. 
ii. Age & sex specific death rates are calculated for males and females for each age-
group. 
iii. The age & sex specific death rates are multiplied by the number of cases in the 
OECD standard population (based on the total number of ischaemic stroke 
hospitalisations in the OECD) 
iv. The age-sex standardised death rate (ASDR) is then calculated as the sum of the age 
& sex specific rates multiplied by the standard population, and divided by the total 
number of cases in the standard population. 
v. Upper and lower confidence intervals are presented at the 95% confidence level, and 
are calculated by  
                             ASDR ± 1.96 * Standard Error of ASDR 
where the standard error is determined from a binomial distribution. 
 Notes Data are based on discharges from publicly funded acute hospitals; private hospitals are not 
included. Data have been analysed at hospital and hospital group level (see Appendix for 
hospital groups). A small number of non-acute hospitals that are not included in the seven 
hospital groups participate in HIPE for historical reasons; these hospitals have been removed 
from this analysis.  
95% confidence intervals have been produced and these should be considered when 
interpreting the age-standardised death rates.  Where the lower limit of the 95% confidence 
interval is above the upper 95% confidence limit of the national rate, it can be said that the 
rate is statistically significantly higher than the national rate at the 95% confidence level. 
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Similarly, where the upper limit of the 95% confidence interval is below the lower 95% 
confidence limit of the national rate, it can be said that the rate is statistically significantly 
lower than the national rate at the 95% confidence level.  Note that hospitals with small 
numbers of cases tend to have unstable rates and wider confidence intervals. For this report 
rates are not displayed for hospitals with less than 100 denominator cases, although the data 
for these hospitals have been included in the calculation of the national rates.  However some 
hospitals with more than 100 cases may still have unstable rates and caution should be 
exercised in interpreting rates with wide confidence intervals.  
It is important to note that transfer patterns between hospitals have the potential to influence 
the in-hospital mortality rates.  For some conditions there can be significant volumes of 
patients being transferred out of hospitals and being transferred into other hospitals. The 
indicators presented in this report are high-level indicators and therefore do not take transfer 
patterns into account. A more refined analysis of transfer patterns would be required to assess 
the full effect of transfers on the in-hospital mortality rates.  
  
Data 
Source(s) 
  
  
Hospital In-Patient Enquiry (HIPE) 
The Healthcare Pricing Office (HPO) manages the HIPE system. For more information on 
HIPE see http://www.hpo.ie. 
The data presented for this indicator are based on analysis of HIPE data carried out by the 
Department of Health using the definitions and methodology developed by the OECD Health 
Care Quality Indicators (HCQI) project.  
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Indicator In-hospital Waiting Time for Hip Fracture Surgery 
Definition The proportion of patients aged 65 years and older with a hip fracture who have surgery 
within two days of admission to hospital.   
Years 
Covered 
National trend: 2004 – 2013 
OECD comparison: 2011 
County of residence: 2011 – 2013 (aggregated)  
Classification Hip fracture diagnostic codes: ICD-9-CM 820 or ICD-10-AM S72.0, S71.1, S72.2 
Hip fracture surgery codes: ICD-9-CM 78.05, 78.15, 78.55, 79.05, 79.15, 79.25, 79.35, 
79.75, 79.85, 81.21, 81.40, 81.51, 81.52, 81.53 or ICD-10-AM ACHI blocks 1479, 1486, 
1487, 1488, 1489, 1491, 1492 
Methodology Numerator: 
Number of hospitalisations with a principal diagnosis of a hip fracture and who had hip 
fracture surgery on the day of admission, 1 day after admission or 2 days after admission in 
a specified year, ages 65 and older. 
Denominator: 
Number of hospitalisations with a principal diagnosis of a hip fracture and who had hip 
fracture surgery during the admission in a specified year, ages 65 and older. 
Exclusions: 
Elective admissions and elective re-admissions 
Data have been calculated according to the methodology used by the OECD Health Care 
Quality Indicators (HCQI) project. It should be noted that the methodology specified by the 
OECD for the2012-2013 data collection allowed countries to define the waiting time for hip 
fracture surgery based on either 48 hours or 2 days. This may reduce the comparability of 
this indicator among OECD countries. The 2014-2015 HCQI data collection defines this 
indicator as surgery within 2 calendar days after admission which will improve the 
comparability of the data.  
 Notes Data are based on discharges from publicly funded acute hospitals; private hospitals are not 
included. A small number of non-acute hospitals that are not included in the seven hospital 
groups participate in HIPE for historical reasons; these hospitals have been removed from 
this analysis.  
Data 
Source(s) 
  
Hospital In-Patient Enquiry (HIPE) 
The Healthcare Pricing Office (HPO) manages the HIPE system. For more information on 
HIPE see http://www.hpo.ie. 
The data presented for this indicator are based on analysis of HIPE data carried out by the 
Department of Health using the definitions and methodology developed by the OECD 
Health Care Quality Indicators (HCQI) project.  
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Indicator Caesarean Section Rate 
Definition The rate of caesarean section deliveries per 100 live births.   
Years 
Covered 
  
National trend: 2004 – 2013 
OECD comparison: 2011 
Hospital & hospital group level: 2013  
Classification Not applicable 
Methodology 
Data are based on the caesarean section rate per 100 live births for total maternities.  
Exclusions: 
 Data exclude births in Mount Carmel Private Hospital, Bon Secours Private 
Hospital (2004-2007) and planned domiciliary home births attended by a self-
employed community midwife. 
 In accordance with WHO reporting guidelines, live births with birth weight <500g 
are excluded.  
 Notes Data are based on total maternities where outcome of delivery is live birth(s) and includes 
total live births, i.e. single and multiple live births. It should be noted that caesarean sections 
rates vary considerably between single and multiple births. 
The rates presented in this report differ slightly from those previously published in the 
National Perinatal Reporting System annual reports. This is due to the exclusion of the 
private maternity hospitals.  
  
Data 
Source(s) 
  
  
National Perinatal Reporting System (NPRS) 
The Healthcare Pricing Office (HPO) manages the NPRS system.  The data presented in this 
report were sourced directly from the Healthcare Pricing Office in December 2014 and were 
based on the methodology used by the OECD for reporting caesarean section rates. For more 
information on NPRS see http://www.hpo.ie 
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Indicator Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection Rates 
Definition The rate of MRSA bloodstream infections in acute hospitals per 1,000 bed days used.    
Years 
Covered 
  
National trend: 2004 – 2013 
  
Classification Not applicable 
Methodology 
MRSA rates are calculated based on the number of MRSA cases per 1,000 bed days used. 
 
 Notes Rates for 2004 and 2005 were calculated for acute public hospitals only as there was no 
denominator data (i.e. bed days used) available for private hospitals.  
  
Data 
Source(s) 
  
  
Health Protection Surveillance Centre 
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Indicator Clostridium Difficile (C Difficile) Infection Rates 
Definition The rate of new cases of Clostridium Difficile in acute hospitals per 10,000 bed days used.    
Years 
Covered 
 
National trend: 2010 – 2013 
Classification Not applicable 
Methodology 
Rates are calculated based on the number of new hospital acquired cases of Clostridium 
Difficile per 10,000 bed days used.  
 Notes Since surveillance began in 2009 there has been a gradual increase in the numbers of 
hospitals participating in the enhanced surveillance system. The numbers of participating 
hospitals should be taken into account when interpreting national trends. 
There is considerable variation in the C. difficile testing methodologies used by participating 
laboratories. Different methodologies have different levels of sensitivity in detecting C. 
difficile therefore inter-hospital comparison of CDI rates is not recommended unless data is 
adjusted for type of testing method used. 
  
Data 
Source(s) 
  
  
Health Protection Surveillance Centre 
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